,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,272525,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4353.0,MPO,https://ctdbase.org/detail.go?type=gene&acc=4353,,,4353,MPO,10116,Rattus norvegicus (Norway rat),Benzo(a)pyrene results in increased activity of MPO protein|[il27 protein co-treated with IFNL3 protein] inhibits the reaction [benzo(a)pyrene results in increased activity of MPO protein]|il27 protein inhibits the reaction [benzo(a)pyrene results in increased activity of MPO protein],,,PMID:34999049,https://www.ncbi.nlm.nih.gov/pubmed/34999049,34999049,,
1,272526,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4354.0,MPP1,https://ctdbase.org/detail.go?type=gene&acc=4354,,,4354,MPP1,44932,Boreogadus saida,[benzo(a)pyrene co-treated with ethinyl estradiol] results in decreased expression of MPP1 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
2,272527,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4354.0,MPP1,https://ctdbase.org/detail.go?type=gene&acc=4354,,,4354,MPP1,9606,Homo sapiens (human),Benzo(a)pyrene affects the methylation of MPP1 5' utr|benzo(a)pyrene affects the methylation of MPP1 promoter|benzo(a)pyrene results in increased methylation of MPP1 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
3,272528,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4354.0,MPP1,https://ctdbase.org/detail.go?type=gene&acc=4354,,,4354,MPP1,9606,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of MPP1 mRNA,,,PMID:26238291|PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/26238291|https://www.ncbi.nlm.nih.gov/pubmed/32234424,26238291|32234424,,
4,272529,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4354.0,MPP1,https://ctdbase.org/detail.go?type=gene&acc=4354,,,4354,MPP1,10090,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of MPP1 mRNA,,,PMID:21715664,https://www.ncbi.nlm.nih.gov/pubmed/21715664,21715664,,
5,272530,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4355.0,MPP2,https://ctdbase.org/detail.go?type=gene&acc=4355,,,4355,MPP2,44932,Boreogadus saida,[benzo(a)pyrene co-treated with ethinyl estradiol] results in decreased expression of MPP2 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
6,272531,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4355.0,MPP2,https://ctdbase.org/detail.go?type=gene&acc=4355,,,4355,MPP2,9606,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of MPP2 5' utr|benzo(a)pyrene affects the methylation of MPP2 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
7,370642,2750,Comparative Toxicogenomics Database (CTD),Ciglitazone,C039671,ciglitazone,https://ctdbase.org/detail.go?type=chem&acc=C039671,6286.0,S100P,https://ctdbase.org/detail.go?type=gene&acc=6286,,,6286,S100P,9606,Homo sapiens (human),[ciglitazone binds to PPARG protein alternative form] which results in increased expression of S100P mrna|[ciglitazone binds to PPARG protein] which results in increased expression of S100P mRNA,,,PMID:16197558,https://www.ncbi.nlm.nih.gov/pubmed/16197558,16197558,,
8,393436,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,4803.0,NGF,https://ctdbase.org/detail.go?type=gene&acc=4803,,,4803,NGF,10090,Mus musculus (house mouse),[diazinon co-treated with NGF protein] results in decreased expression of SLC17A8 mrna|[diazinon co-treated with NGF protein] results in increased expression of SLC1A5 mrna|[diazinon co-treated with NGF protein] results in increased expression of SLC1A4 mRNA,,,PMID:20600679,https://www.ncbi.nlm.nih.gov/pubmed/20600679,20600679,,
9,393437,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,4803.0,NGF,https://ctdbase.org/detail.go?type=gene&acc=4803,,,4803,NGF,10090,Mus musculus (house mouse),Diazinon results in decreased expression of NGF mRNA,,,PMID:23212306,https://www.ncbi.nlm.nih.gov/pubmed/23212306,23212306,,
10,393438,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,4803.0,NGF,https://ctdbase.org/detail.go?type=gene&acc=4803,,,4803,NGF,10090,Mus musculus (house mouse),[TLR4 protein mutant form results in increased susceptibility to diazinon] which results in decreased expression of NGF mRNA,,,PMID:22428454,https://www.ncbi.nlm.nih.gov/pubmed/22428454,22428454,,
11,393439,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,4803.0,NGF,https://ctdbase.org/detail.go?type=gene&acc=4803,,,4803,NGF,10116,Rattus norvegicus (Norway rat),Diazinon affects the expression of NGF mRNA,,,PMID:19130878,https://www.ncbi.nlm.nih.gov/pubmed/19130878,19130878,,
12,397015,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,5465.0,PPARA,https://ctdbase.org/detail.go?type=gene&acc=5465,,,5465,PPARA,9606,Homo sapiens (human),Diazinon results in increased methylation of PPARA gene,,,PMID:22964155,https://www.ncbi.nlm.nih.gov/pubmed/22964155,22964155,,
13,397016,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,5468.0,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468,PPARG,9606,Homo sapiens (human),Diazinon results in increased activity of PPARG protein,,,PMID:28728110,https://www.ncbi.nlm.nih.gov/pubmed/28728110,28728110,,
14,397017,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,5468.0,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468,PPARG,10090,Mus musculus (house mouse),Fulvestrant inhibits the reaction [diazinon results in increased expression of PPARG protein]|diazinon results in increased expression of PPARG protein,,,PMID:33872936,https://www.ncbi.nlm.nih.gov/pubmed/33872936,33872936,,
15,370440,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9922.0,IQSEC1,https://ctdbase.org/detail.go?type=gene&acc=9922,,,9922,IQSEC1,9606,Homo sapiens (human),Valproic acid affects the expression of IQSEC1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
16,370441,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9922.0,IQSEC1,https://ctdbase.org/detail.go?type=gene&acc=9922,,,9922,IQSEC1,9606,Homo sapiens (human),Valproic acid results in increased methylation of IQSEC1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
17,393787,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,23302.0,WSCD1,https://ctdbase.org/detail.go?type=gene&acc=23302,,,23302,WSCD1,10090,Mus musculus (house mouse),Valproic acid affects the expression of WSCD1 mRNA,,,PMID:17963808,https://www.ncbi.nlm.nih.gov/pubmed/17963808,17963808,,
18,393788,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9671.0,WSCD2,https://ctdbase.org/detail.go?type=gene&acc=9671,,,9671,WSCD2,9606,Homo sapiens (human),Valproic acid affects the expression of WSCD2 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
19,393789,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9671.0,WSCD2,https://ctdbase.org/detail.go?type=gene&acc=9671,,,9671,WSCD2,9606,Homo sapiens (human),Valproic acid results in increased expression of WSCD2 mRNA,,,PMID:23179753|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386,23179753|27188386,,
20,393790,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7490.0,WT1,https://ctdbase.org/detail.go?type=gene&acc=7490,,,7490,WT1,9606,Homo sapiens (human),CEBPA protein affects the reaction [valproic acid results in increased expression of WT1 mrna],,,PMID:32623605,https://www.ncbi.nlm.nih.gov/pubmed/32623605,32623605,,
21,393791,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7490.0,WT1,https://ctdbase.org/detail.go?type=gene&acc=7490,,,7490,WT1,9606,Homo sapiens (human),Valproic acid results in decreased methylation of WT1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
22,393792,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7490.0,WT1,https://ctdbase.org/detail.go?type=gene&acc=7490,,,7490,WT1,9606,Homo sapiens (human),Valproic acid results in increased expression of WT1 mRNA,,,PMID:28001369|PMID:32623605,https://www.ncbi.nlm.nih.gov/pubmed/28001369|https://www.ncbi.nlm.nih.gov/pubmed/32623605,28001369|32623605,,
23,393793,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51352.0,WT1-AS,https://ctdbase.org/detail.go?type=gene&acc=51352,,,51352,WT1-AS,9606,Homo sapiens (human),Valproic acid results in decreased methylation of WT1-AS gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
24,393794,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9589.0,WTAP,https://ctdbase.org/detail.go?type=gene&acc=9589,,,9589,WTAP,9606,Homo sapiens (human),Valproic acid affects the expression of WTAP mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
25,393943,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,140738.0,TMEM37,https://ctdbase.org/detail.go?type=gene&acc=140738,,,140738,TMEM37,9606,Homo sapiens (human),Valproic acid results in increased methylation of TMEM37 gene|valproic acid results in decreased expression of TMEM37 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
26,393944,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,140738.0,TMEM37,https://ctdbase.org/detail.go?type=gene&acc=140738,,,140738,TMEM37,9606,Homo sapiens (human),Valproic acid results in increased expression of TMEM37 mRNA,,,PMID:24935251|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,24935251|26272509|28001369,,
27,393945,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,79041.0,TMEM38A,https://ctdbase.org/detail.go?type=gene&acc=79041,,,79041,TMEM38A,7955,Danio rerio (zebrafish),Valproic acid results in decreased expression of TMEM38A mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
28,393946,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,79041.0,TMEM38A,https://ctdbase.org/detail.go?type=gene&acc=79041,,,79041,TMEM38A,10090,Mus musculus (house mouse),Valproic acid affects the expression of TMEM38A mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
29,393947,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55151.0,TMEM38B,https://ctdbase.org/detail.go?type=gene&acc=55151,,,55151,TMEM38B,9606,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM38B mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
30,393948,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55151.0,TMEM38B,https://ctdbase.org/detail.go?type=gene&acc=55151,,,55151,TMEM38B,9606,Homo sapiens (human),Valproic acid affects the expression of TMEM38B mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
31,393949,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55151.0,TMEM38B,https://ctdbase.org/detail.go?type=gene&acc=55151,,,55151,TMEM38B,9606,Homo sapiens (human),Valproic acid results in increased expression of TMEM38B mRNA,,,PMID:23179753|PMID:24935251|PMID:26272509|PMID:28001369|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369|https://www.ncbi.nlm.nih.gov/pubmed/29154799,23179753|24935251|26272509|28001369|29154799,,
32,393950,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55254.0,TMEM39A,https://ctdbase.org/detail.go?type=gene&acc=55254,,,55254,TMEM39A,9606,Homo sapiens (human),Valproic acid affects the expression of TMEM39A mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
33,394444,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,11059.0,WWP1,https://ctdbase.org/detail.go?type=gene&acc=11059,,,11059,WWP1,9606,Homo sapiens (human),Valproic acid results in increased expression of WWP1 mRNA,,,PMID:19101580,https://www.ncbi.nlm.nih.gov/pubmed/19101580,19101580,,
34,394617,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,112487.0,DTD2,https://ctdbase.org/detail.go?type=gene&acc=112487,,,112487,DTD2,9606,Homo sapiens (human),Valproic acid affects the expression of DTD2 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
35,394618,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,112487.0,DTD2,https://ctdbase.org/detail.go?type=gene&acc=112487,,,112487,DTD2,9606,Homo sapiens (human),Valproic acid results in increased expression of DTD2 mRNA,,,PMID:23179753|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|26272509,,
36,394619,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51514.0,DTL,https://ctdbase.org/detail.go?type=gene&acc=51514,,,51514,DTL,9606,Homo sapiens (human),Valproic acid results in decreased expression of DTL mRNA,,,PMID:23179753|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386,23179753|27188386,,
37,394620,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51514.0,DTL,https://ctdbase.org/detail.go?type=gene&acc=51514,,,51514,DTL,9606,Homo sapiens (human),Valproic acid results in decreased methylation of DTL gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
38,394621,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,1837.0,DTNA,https://ctdbase.org/detail.go?type=gene&acc=1837,,,1837,DTNA,9606,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DTNA mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
39,394622,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,1837.0,DTNA,https://ctdbase.org/detail.go?type=gene&acc=1837,,,1837,DTNA,9606,Homo sapiens (human),Valproic acid affects the expression of DTNA mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
40,394954,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,331.0,XIAP,https://ctdbase.org/detail.go?type=gene&acc=331,,,331,XIAP,10090,Mus musculus (house mouse),Valproic acid affects the expression of XIAP mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
41,395468,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51249.0,TMEM69,https://ctdbase.org/detail.go?type=gene&acc=51249,,,51249,TMEM69,9606,Homo sapiens (human),Valproic acid affects the expression of TMEM69 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
42,395469,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51249.0,TMEM69,https://ctdbase.org/detail.go?type=gene&acc=51249,,,51249,TMEM69,9606,Homo sapiens (human),Valproic acid results in increased expression of TMEM69 mRNA,,,PMID:23179753|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/29154799,23179753|29154799,,
43,395470,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51249.0,TMEM69,https://ctdbase.org/detail.go?type=gene&acc=51249,,,51249,TMEM69,10090,Mus musculus (house mouse),Valproic acid affects the expression of TMEM69 mRNA,,,PMID:17963808,https://www.ncbi.nlm.nih.gov/pubmed/17963808,17963808,,
44,395471,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,54968.0,TMEM70,https://ctdbase.org/detail.go?type=gene&acc=54968,,,54968,TMEM70,9606,Homo sapiens (human),Valproic acid affects the expression of TMEM70 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
45,395472,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,54968.0,TMEM70,https://ctdbase.org/detail.go?type=gene&acc=54968,,,54968,TMEM70,9606,Homo sapiens (human),Valproic acid results in increased expression of TMEM70 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
46,395473,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,137835.0,TMEM71,https://ctdbase.org/detail.go?type=gene&acc=137835,,,137835,TMEM71,9606,Homo sapiens (human),Valproic acid results in increased expression of TMEM71 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
47,395474,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,137835.0,TMEM71,https://ctdbase.org/detail.go?type=gene&acc=137835,,,137835,TMEM71,10116,Rattus norvegicus (Norway rat),Valproic acid results in decreased expression of TMEM71 mRNA,,,PMID:35594946,https://www.ncbi.nlm.nih.gov/pubmed/35594946,35594946,,
48,395996,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,78986.0,DUSP26,https://ctdbase.org/detail.go?type=gene&acc=78986,,,78986,DUSP26,9606,Homo sapiens (human),Valproic acid affects the expression of DUSP26 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
49,395997,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,78986.0,DUSP26,https://ctdbase.org/detail.go?type=gene&acc=78986,,,78986,DUSP26,9606,Homo sapiens (human),Valproic acid results in decreased expression of DUSP26 mRNA,,,PMID:23527032,https://www.ncbi.nlm.nih.gov/pubmed/23527032,23527032,,
50,395998,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,78986.0,DUSP26,https://ctdbase.org/detail.go?type=gene&acc=78986,,,78986,DUSP26,9606,Homo sapiens (human),Valproic acid results in increased expression of DUSP26 mRNA,,,PMID:24383497|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,24383497|26272509|28001369,,
51,395999,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,285193.0,DUSP28,https://ctdbase.org/detail.go?type=gene&acc=285193,,,285193,DUSP28,9606,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DUSP28 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
52,396000,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,285193.0,DUSP28,https://ctdbase.org/detail.go?type=gene&acc=285193,,,285193,DUSP28,9606,Homo sapiens (human),Valproic acid affects the expression of DUSP28 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
53,396001,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,285193.0,DUSP28,https://ctdbase.org/detail.go?type=gene&acc=285193,,,285193,DUSP28,9606,Homo sapiens (human),Valproic acid results in decreased expression of DUSP28 mRNA,,,PMID:23179753|PMID:24935251|PMID:26272509|PMID:28001369|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369|https://www.ncbi.nlm.nih.gov/pubmed/29154799,23179753|24935251|26272509|28001369|29154799,,
54,396002,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,285193.0,DUSP28,https://ctdbase.org/detail.go?type=gene&acc=285193,,,285193,DUSP28,9606,Homo sapiens (human),Valproic acid results in increased methylation of DUSP28 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
55,396853,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,54432.0,YIPF1,https://ctdbase.org/detail.go?type=gene&acc=54432,,,54432,YIPF1,9606,Homo sapiens (human),Valproic acid results in increased expression of YIPF1 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
56,396854,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,78992.0,YIPF2,https://ctdbase.org/detail.go?type=gene&acc=78992,,,78992,YIPF2,9606,Homo sapiens (human),Valproic acid results in increased methylation of YIPF2 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
57,396855,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,25844.0,YIPF3,https://ctdbase.org/detail.go?type=gene&acc=25844,,,25844,YIPF3,9606,Homo sapiens (human),Valproic acid results in decreased expression of YIPF3 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
58,396856,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,25844.0,YIPF3,https://ctdbase.org/detail.go?type=gene&acc=25844,,,25844,YIPF3,10090,Mus musculus (house mouse),Valproic acid affects the expression of YIPF3 mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
59,396857,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84272.0,YIPF4,https://ctdbase.org/detail.go?type=gene&acc=84272,,,84272,YIPF4,9606,Homo sapiens (human),Valproic acid results in increased expression of YIPF4 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
60,397008,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84000.0,TMPRSS13,https://ctdbase.org/detail.go?type=gene&acc=84000,,,84000,TMPRSS13,9606,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMPRSS13 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
61,397009,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84000.0,TMPRSS13,https://ctdbase.org/detail.go?type=gene&acc=84000,,,84000,TMPRSS13,9606,Homo sapiens (human),Valproic acid results in increased expression of TMPRSS13 mRNA,,,PMID:24383497|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24383497|26272509,,
62,397010,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,559754.0,TMPRSS13A,https://ctdbase.org/detail.go?type=gene&acc=559754,,,559754,tmprss13a,7955,Danio rerio (zebrafish),Valproic acid affects the expression of TMPRSS13A mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
63,397011,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7113.0,TMPRSS2,https://ctdbase.org/detail.go?type=gene&acc=7113,,,7113,TMPRSS2,9606,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMPRSS2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
64,397012,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7113.0,TMPRSS2,https://ctdbase.org/detail.go?type=gene&acc=7113,,,7113,TMPRSS2,9606,Homo sapiens (human),Valproic acid affects the expression of TMPRSS2 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
65,397013,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7113.0,TMPRSS2,https://ctdbase.org/detail.go?type=gene&acc=7113,,,7113,TMPRSS2,9606,Homo sapiens (human),Valproic acid results in increased expression of TMPRSS2 mRNA,,,PMID:23179753|PMID:24383497|PMID:26272509|PMID:32808185,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/32808185,23179753|24383497|26272509|32808185,,
66,397014,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7113.0,TMPRSS2,https://ctdbase.org/detail.go?type=gene&acc=7113,,,7113,TMPRSS2,10116,Rattus norvegicus (Norway rat),Valproic acid results in increased expression of TMPRSS2 mRNA,,,PMID:32808185,https://www.ncbi.nlm.nih.gov/pubmed/32808185,32808185,,
67,397792,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51441.0,YTHDF2,https://ctdbase.org/detail.go?type=gene&acc=51441,,,51441,YTHDF2,10090,Mus musculus (house mouse),Valproic acid results in decreased expression of YTHDF2 mRNA,,,PMID:19136453|PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/19136453|https://www.ncbi.nlm.nih.gov/pubmed/21427059,19136453|21427059,,
68,394264,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,3055.0,HCK,https://ctdbase.org/detail.go?type=gene&acc=3055,,,3055,HCK,10116,Rattus norvegicus (Norway rat),Endosulfan results in increased expression of HCK mRNA,,,PMID:29391264,https://www.ncbi.nlm.nih.gov/pubmed/29391264,29391264,,
69,394265,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,3065.0,HDAC1,https://ctdbase.org/detail.go?type=gene&acc=3065,,,3065,HDAC1,9606,Homo sapiens (human),Endosulfan results in increased expression of HDAC1 mrna|endosulfan results in increased expression of HDAC1 protein,,,PMID:29054638,https://www.ncbi.nlm.nih.gov/pubmed/29054638,29054638,,
70,394266,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,3065.0,HDAC1,https://ctdbase.org/detail.go?type=gene&acc=3065,,,3065,HDAC1,10116,Rattus norvegicus (Norway rat),Endosulfan results in decreased expression of HDAC1 mRNA,,,PMID:29391264,https://www.ncbi.nlm.nih.gov/pubmed/29391264,29391264,,
71,394267,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,3066.0,HDAC2,https://ctdbase.org/detail.go?type=gene&acc=3066,,,3066,HDAC2,9606,Homo sapiens (human),Endosulfan results in decreased expression of HDAC2 mRNA,,,PMID:30090376,https://www.ncbi.nlm.nih.gov/pubmed/30090376,30090376,,
72,394268,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,8841.0,HDAC3,https://ctdbase.org/detail.go?type=gene&acc=8841,,,8841,HDAC3,9606,Homo sapiens (human),Endosulfan results in increased expression of HDAC3 mrna|endosulfan results in increased expression of HDAC3 protein,,,PMID:29054638,https://www.ncbi.nlm.nih.gov/pubmed/29054638,29054638,,
73,394269,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,9759.0,HDAC4,https://ctdbase.org/detail.go?type=gene&acc=9759,,,9759,HDAC4,9606,Homo sapiens (human),Endosulfan results in decreased expression of HDAC4 protein|endosulfan results in decreased expression of HDAC4 mRNA,,,PMID:29054638,https://www.ncbi.nlm.nih.gov/pubmed/29054638,29054638,,
74,395297,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,79987.0,SVEP1,https://ctdbase.org/detail.go?type=gene&acc=79987,,,79987,SVEP1,10116,Rattus norvegicus (Norway rat),Endosulfan results in decreased expression of SVEP1 mRNA,,,PMID:29391264,https://www.ncbi.nlm.nih.gov/pubmed/29391264,29391264,,
75,395298,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,6840.0,SVIL,https://ctdbase.org/detail.go?type=gene&acc=6840,,,6840,SVIL,10116,Rattus norvegicus (Norway rat),Endosulfan results in decreased expression of SVIL mRNA,,,PMID:29391264,https://www.ncbi.nlm.nih.gov/pubmed/29391264,29391264,,
76,395299,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,258010.0,SVIP,https://ctdbase.org/detail.go?type=gene&acc=258010,,,258010,SVIP,10116,Rattus norvegicus (Norway rat),Endosulfan results in increased expression of SVIP mRNA,,,PMID:31464424,https://www.ncbi.nlm.nih.gov/pubmed/31464424,31464424,,
77,395300,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,55638.0,SYBU,https://ctdbase.org/detail.go?type=gene&acc=55638,,,55638,SYBU,10116,Rattus norvegicus (Norway rat),Endosulfan results in increased expression of SYBU mRNA,,,PMID:29391264,https://www.ncbi.nlm.nih.gov/pubmed/29391264,29391264,,
78,395301,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,8189.0,SYMPK,https://ctdbase.org/detail.go?type=gene&acc=8189,,,8189,SYMPK,10116,Rattus norvegicus (Norway rat),Endosulfan results in increased expression of SYMPK mRNA,,,PMID:31464424,https://www.ncbi.nlm.nih.gov/pubmed/31464424,31464424,,
79,395302,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,6854.0,SYN2,https://ctdbase.org/detail.go?type=gene&acc=6854,,,6854,SYN2,10116,Rattus norvegicus (Norway rat),Endosulfan results in decreased expression of SYN2 mRNA,,,PMID:29391264,https://www.ncbi.nlm.nih.gov/pubmed/29391264,29391264,,
80,395303,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,81493.0,SYNC,https://ctdbase.org/detail.go?type=gene&acc=81493,,,81493,SYNC,10116,Rattus norvegicus (Norway rat),Endosulfan results in decreased expression of SYNC mRNA,,,PMID:29391264,https://www.ncbi.nlm.nih.gov/pubmed/29391264,29391264,,
81,395304,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,8831.0,SYNGAP1,https://ctdbase.org/detail.go?type=gene&acc=8831,,,8831,SYNGAP1,10116,Rattus norvegicus (Norway rat),Endosulfan results in decreased expression of SYNGAP1 mRNA,,,PMID:29391264,https://www.ncbi.nlm.nih.gov/pubmed/29391264,29391264,,
82,397180,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,123688.0,HYKK,https://ctdbase.org/detail.go?type=gene&acc=123688,,,123688,HYKK,10116,Rattus norvegicus (Norway rat),Endosulfan results in decreased expression of HYKK mRNA,,,PMID:29391264,https://www.ncbi.nlm.nih.gov/pubmed/29391264,29391264,,
83,397181,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,10525.0,HYOU1,https://ctdbase.org/detail.go?type=gene&acc=10525,,,10525,HYOU1,10116,Rattus norvegicus (Norway rat),Endosulfan affects the expression of HYOU1 mRNA,,,PMID:29391264,https://www.ncbi.nlm.nih.gov/pubmed/29391264,29391264,,
84,397182,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,10525.0,HYOU1,https://ctdbase.org/detail.go?type=gene&acc=10525,,,10525,HYOU1,10116,Rattus norvegicus (Norway rat),Endosulfan results in increased expression of HYOU1 mRNA,,,PMID:31464424,https://www.ncbi.nlm.nih.gov/pubmed/31464424,31464424,,
85,395804,3291,Comparative Toxicogenomics Database (CTD),Ethosuximide,D005013,Ethosuximide,https://ctdbase.org/detail.go?type=chem&acc=D005013,39734.0,GXIVSPLA2,https://ctdbase.org/detail.go?type=gene&acc=39734,,,39734,GXIVsPLA2,7227,Drosophila melanogaster (fruit fly),[ethosuximide co-treated with pentylenetetrazole] affects the expression of GXIVSPLA2 mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,
86,395805,3291,Comparative Toxicogenomics Database (CTD),Ethosuximide,D005013,Ethosuximide,https://ctdbase.org/detail.go?type=chem&acc=D005013,3109.0,HLA-DMB,https://ctdbase.org/detail.go?type=gene&acc=3109,,,3109,HLA-DMB,9606,Homo sapiens (human),Ethosuximide affects the expression of HLA-DMB mRNA,,,PMID:25811541,https://www.ncbi.nlm.nih.gov/pubmed/25811541,25811541,,
87,395806,3291,Comparative Toxicogenomics Database (CTD),Ethosuximide,D005013,Ethosuximide,https://ctdbase.org/detail.go?type=chem&acc=D005013,3113.0,HLA-DPA1,https://ctdbase.org/detail.go?type=gene&acc=3113,,,3113,HLA-DPA1,9606,Homo sapiens (human),Ethosuximide affects the expression of HLA-DPA1 mRNA,,,PMID:25811541,https://www.ncbi.nlm.nih.gov/pubmed/25811541,25811541,,
88,395807,3291,Comparative Toxicogenomics Database (CTD),Ethosuximide,D005013,Ethosuximide,https://ctdbase.org/detail.go?type=chem&acc=D005013,38389.0,HSP83,https://ctdbase.org/detail.go?type=gene&acc=38389,,,38389,Hsp83,7227,Drosophila melanogaster (fruit fly),[ethosuximide co-treated with pentylenetetrazole] affects the expression of HSP83 mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,
89,395808,3291,Comparative Toxicogenomics Database (CTD),Ethosuximide,D005013,Ethosuximide,https://ctdbase.org/detail.go?type=chem&acc=D005013,3760.0,KCNJ3,https://ctdbase.org/detail.go?type=gene&acc=3760,,,3760,KCNJ3,10090,Mus musculus (house mouse),Ethosuximide inhibits the reaction [ethanol promotes the reaction [[KCNJ3 protein binds to KCNJ6 protein] which results in increased transport of potassium]]|ethosuximide inhibits the reaction [[KCNJ5 protein binds to KCNJ3 protein] which results in increased transport of potassium]|ethosuximide inhibits the reaction [[KCNJ3 protein binds to KCNJ6 protein] which results in increased transport of potassium],,,PMID:18977371,https://www.ncbi.nlm.nih.gov/pubmed/18977371,18977371,,
90,395809,3291,Comparative Toxicogenomics Database (CTD),Ethosuximide,D005013,Ethosuximide,https://ctdbase.org/detail.go?type=chem&acc=D005013,3762.0,KCNJ5,https://ctdbase.org/detail.go?type=gene&acc=3762,,,3762,KCNJ5,10116,Rattus norvegicus (Norway rat),Ethosuximide inhibits the reaction [[KCNJ5 protein binds to KCNJ3 protein] which results in increased transport of potassium],,,PMID:18977371,https://www.ncbi.nlm.nih.gov/pubmed/18977371,18977371,,
91,397703,3293,Comparative Toxicogenomics Database (CTD),Ethoxyquin,D005015,Ethoxyquin,https://ctdbase.org/detail.go?type=chem&acc=D005015,1728.0,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728,NQO1,10090,Mus musculus (house mouse),Ethoxyquin results in increased expression of NQO1 protein,,,PMID:11309284,https://www.ncbi.nlm.nih.gov/pubmed/11309284,11309284,,
92,397704,3293,Comparative Toxicogenomics Database (CTD),Ethoxyquin,D005015,Ethoxyquin,https://ctdbase.org/detail.go?type=chem&acc=D005015,1728.0,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728,NQO1,10116,Rattus norvegicus (Norway rat),Ethoxyquin promotes the reaction [methylcholanthrene results in increased activity of NQO1 protein]|methylcholanthrene promotes the reaction [ethoxyquin results in increased activity of NQO1 protein],,,PMID:16906435,https://www.ncbi.nlm.nih.gov/pubmed/16906435,16906435,,
93,397705,3293,Comparative Toxicogenomics Database (CTD),Ethoxyquin,D005015,Ethoxyquin,https://ctdbase.org/detail.go?type=chem&acc=D005015,1728.0,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728,NQO1,10116,Rattus norvegicus (Norway rat),Ethoxyquin results in increased activity of NQO1 protein,,,PMID:16045903|PMID:16906435,https://www.ncbi.nlm.nih.gov/pubmed/16045903|https://www.ncbi.nlm.nih.gov/pubmed/16906435,16045903|16906435,,
94,397706,3293,Comparative Toxicogenomics Database (CTD),Ethoxyquin,D005015,Ethoxyquin,https://ctdbase.org/detail.go?type=chem&acc=D005015,1728.0,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728,NQO1,10116,Rattus norvegicus (Norway rat),Ethoxyquin results in increased expression of NQO1 mRNA,,,PMID:19695238,https://www.ncbi.nlm.nih.gov/pubmed/19695238,19695238,,
95,393612,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,56999.0,ADAMTS9,https://ctdbase.org/detail.go?type=gene&acc=56999,,,56999,ADAMTS9,9606,Homo sapiens (human),TP53 protein affects the reaction [fluorouracil results in decreased expression of ADAMTS9 mrna],,,PMID:15016801,https://www.ncbi.nlm.nih.gov/pubmed/15016801,15016801,,
96,393613,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,115.0,ADCY9,https://ctdbase.org/detail.go?type=gene&acc=115,,,115,ADCY9,9606,Homo sapiens (human),Fluorouracil results in decreased expression of ADCY9 mRNA,,,PMID:19219653,https://www.ncbi.nlm.nih.gov/pubmed/19219653,19219653,,
97,393614,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,9289.0,ADGRG1,https://ctdbase.org/detail.go?type=gene&acc=9289,,,9289,ADGRG1,9606,Homo sapiens (human),ADGRG1 protein affects the susceptibility to fluorouracil,,,PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16217747,16217747,,
98,393615,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,57211.0,ADGRG6,https://ctdbase.org/detail.go?type=gene&acc=57211,,,57211,ADGRG6,9606,Homo sapiens (human),ADGRG6 protein affects the susceptibility to fluorouracil,,,PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16217747,16217747,,
99,393616,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,23266.0,ADGRL2,https://ctdbase.org/detail.go?type=gene&acc=23266,,,23266,ADGRL2,9606,Homo sapiens (human),ADGRL2 protein affects the susceptibility to fluorouracil,,,PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16217747,16217747,,
100,393617,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,10974.0,ADIRF,https://ctdbase.org/detail.go?type=gene&acc=10974,,,10974,ADIRF,9606,Homo sapiens (human),Fluorouracil results in increased expression of ADIRF mRNA,,,PMID:17039268,https://www.ncbi.nlm.nih.gov/pubmed/17039268,17039268,,
101,393618,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,133.0,ADM,https://ctdbase.org/detail.go?type=gene&acc=133,,,133,ADM,9606,Homo sapiens (human),ADM protein affects the susceptibility to fluorouracil,,,PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16217747,16217747,,
102,393619,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,159.0,ADSS2,https://ctdbase.org/detail.go?type=gene&acc=159,,,159,ADSS2,9606,Homo sapiens (human),Fluorouracil results in decreased expression of ADSS2 mRNA,,,PMID:16709241,https://www.ncbi.nlm.nih.gov/pubmed/16709241,16709241,,
103,393620,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,159.0,ADSS2,https://ctdbase.org/detail.go?type=gene&acc=159,,,159,ADSS2,9606,Homo sapiens (human),Fluorouracil results in increased expression of ADSS2 protein,,,PMID:15585135|PMID:16803524,https://www.ncbi.nlm.nih.gov/pubmed/15585135|https://www.ncbi.nlm.nih.gov/pubmed/16803524,15585135|16803524,,
104,394788,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,375248.0,ANKRD36,https://ctdbase.org/detail.go?type=gene&acc=375248,,,375248,ANKRD36,9606,Homo sapiens (human),Fluorouracil results in increased expression of ANKRD36 mRNA,,,PMID:16510598,https://www.ncbi.nlm.nih.gov/pubmed/16510598,16510598,,
105,395665,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,467.0,ATF3,https://ctdbase.org/detail.go?type=gene&acc=467,,,467,ATF3,9606,Homo sapiens (human),Fluorouracil results in increased expression of ATF3 protein,,,PMID:14665630,https://www.ncbi.nlm.nih.gov/pubmed/14665630,14665630,,
106,395666,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,467.0,ATF3,https://ctdbase.org/detail.go?type=gene&acc=467,,,467,ATF3,9606,Homo sapiens (human),TP53 protein affects the reaction [fluorouracil results in increased expression of ATF3 mrna],,,PMID:15016801,https://www.ncbi.nlm.nih.gov/pubmed/15016801,15016801,,
107,395667,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,468.0,ATF4,https://ctdbase.org/detail.go?type=gene&acc=468,,,468,ATF4,9606,Homo sapiens (human),Fluorouracil results in increased expression of ATF4 protein,,,PMID:29879413,https://www.ncbi.nlm.nih.gov/pubmed/29879413,29879413,,
108,395668,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,22926.0,ATF6,https://ctdbase.org/detail.go?type=gene&acc=22926,,,22926,ATF6,9606,Homo sapiens (human),Fluorouracil affects the expression of ATF6 mRNA,,,PMID:34151400,https://www.ncbi.nlm.nih.gov/pubmed/34151400,34151400,,
109,395669,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,9140.0,ATG12,https://ctdbase.org/detail.go?type=gene&acc=9140,,,9140,ATG12,9606,Homo sapiens (human),Fluorouracil results in decreased expression of ATG12 mRNA,,,PMID:16510598,https://www.ncbi.nlm.nih.gov/pubmed/16510598,16510598,,
110,395670,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,472.0,ATM,https://ctdbase.org/detail.go?type=gene&acc=472,,,472,ATM,9606,Homo sapiens (human),ATM protein results in decreased susceptibility to fluorouracil,,,PMID:35608750,https://www.ncbi.nlm.nih.gov/pubmed/35608750,35608750,,
111,397707,3396,BindingDB,Fluspirilene,26948,"8-[4,4-bis(4-fluorophenyl)butyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26948,2210.0,Nociceptin receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2210,P41146,Nociceptin receptor,4987,OPRL1,9606,Homo sapiens (human),,Ki (nM),500.0,PMID:19147350|DOI:10.1016/j.bmcl.2008.12.092,https://www.ncbi.nlm.nih.gov/pubmed/19147350|https://doi.org/10.1016/j.bmcl.2008.12.092,19147350,10.1016/j.bmcl.2008.12.092,
112,397708,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,117903916.0,NAA12,https://ctdbase.org/detail.go?type=gene&acc=117903916,,,117903916,Naa12,10116,Rattus norvegicus (Norway rat),Flutamide results in increased expression of NAA12 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
113,397709,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,80155.0,NAA15,https://ctdbase.org/detail.go?type=gene&acc=80155,,,80155,NAA15,10116,Rattus norvegicus (Norway rat),Flutamide results in increased expression of NAA15 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
114,397710,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,51126.0,NAA20,https://ctdbase.org/detail.go?type=gene&acc=51126,,,51126,NAA20,10116,Rattus norvegicus (Norway rat),Flutamide results in increased expression of NAA20 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
115,397711,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,60560.0,NAA35,https://ctdbase.org/detail.go?type=gene&acc=60560,,,60560,NAA35,7955,Danio rerio (zebrafish),Flutamide results in increased expression of NAA35 mRNA,,,PMID:21126777,https://www.ncbi.nlm.nih.gov/pubmed/21126777,21126777,,
116,397712,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,60560.0,NAA35,https://ctdbase.org/detail.go?type=gene&acc=60560,,,60560,NAA35,10116,Rattus norvegicus (Norway rat),Flutamide results in increased expression of NAA35 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
117,400802,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,10412.0,NSA2,https://ctdbase.org/detail.go?type=gene&acc=10412,,,10412,NSA2,10116,Rattus norvegicus (Norway rat),Flutamide results in increased expression of NSA2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
118,400803,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,4905.0,NSF,https://ctdbase.org/detail.go?type=gene&acc=4905,,,4905,NSF,10116,Rattus norvegicus (Norway rat),Flutamide results in increased expression of NSF mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
119,400804,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,55968.0,NSFL1C,https://ctdbase.org/detail.go?type=gene&acc=55968,,,55968,NSFL1C,10116,Rattus norvegicus (Norway rat),Flutamide results in increased expression of NSFL1C mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
120,400805,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,197370.0,NSMCE1,https://ctdbase.org/detail.go?type=gene&acc=197370,,,197370,NSMCE1,10116,Rattus norvegicus (Norway rat),Flutamide results in increased expression of NSMCE1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
121,400806,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,286053.0,NSMCE2,https://ctdbase.org/detail.go?type=gene&acc=286053,,,286053,NSMCE2,10116,Rattus norvegicus (Norway rat),Flutamide results in increased expression of NSMCE2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
122,400807,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,54780.0,NSMCE4A,https://ctdbase.org/detail.go?type=gene&acc=54780,,,54780,NSMCE4A,7955,Danio rerio (zebrafish),Flutamide results in decreased expression of NSMCE4A mRNA,,,PMID:21126777,https://www.ncbi.nlm.nih.gov/pubmed/21126777,21126777,,
123,400808,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,26012.0,NSMF,https://ctdbase.org/detail.go?type=gene&acc=26012,,,26012,NSMF,10116,Rattus norvegicus (Norway rat),Flutamide results in decreased expression of NSMF mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
124,400809,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,54888.0,NSUN2,https://ctdbase.org/detail.go?type=gene&acc=54888,,,54888,NSUN2,10116,Rattus norvegicus (Norway rat),Flutamide results in increased expression of NSUN2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
125,400810,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,387338.0,NSUN4,https://ctdbase.org/detail.go?type=gene&acc=387338,,,387338,NSUN4,10116,Rattus norvegicus (Norway rat),Flutamide results in increased expression of NSUN4 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
126,395993,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,56479.0,KCNQ5,https://ctdbase.org/detail.go?type=gene&acc=56479,,,56479,KCNQ5,10116,Rattus norvegicus (Norway rat),Gentamicins results in increased expression of KCNQ5 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
127,395994,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,283518.0,KCNRG,https://ctdbase.org/detail.go?type=gene&acc=283518,,,283518,KCNRG,10116,Rattus norvegicus (Norway rat),Gentamicins results in decreased expression of KCNRG mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
128,395995,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,3790.0,KCNS3,https://ctdbase.org/detail.go?type=gene&acc=3790,,,3790,KCNS3,10116,Rattus norvegicus (Norway rat),Gentamicins results in decreased expression of KCNS3 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
129,396181,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,57582.0,KCNT1,https://ctdbase.org/detail.go?type=gene&acc=57582,,,57582,KCNT1,10116,Rattus norvegicus (Norway rat),Gentamicins results in increased expression of KCNT1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
130,396182,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,343450.0,KCNT2,https://ctdbase.org/detail.go?type=gene&acc=343450,,,343450,KCNT2,10116,Rattus norvegicus (Norway rat),Gentamicins results in increased expression of KCNT2 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
131,397548,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,151230.0,KLHL23,https://ctdbase.org/detail.go?type=gene&acc=151230,,,151230,KLHL23,10116,Rattus norvegicus (Norway rat),Gentamicins results in decreased expression of KLHL23 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
132,397549,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,54800.0,KLHL24,https://ctdbase.org/detail.go?type=gene&acc=54800,,,54800,KLHL24,10116,Rattus norvegicus (Norway rat),Gentamicins results in increased expression of KLHL24 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
133,397550,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,64410.0,KLHL25,https://ctdbase.org/detail.go?type=gene&acc=64410,,,64410,KLHL25,10116,Rattus norvegicus (Norway rat),Gentamicins results in decreased expression of KLHL25 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
134,397551,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,54813.0,KLHL28,https://ctdbase.org/detail.go?type=gene&acc=54813,,,54813,KLHL28,10116,Rattus norvegicus (Norway rat),Gentamicins results in decreased expression of KLHL28 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
135,397552,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,26249.0,KLHL3,https://ctdbase.org/detail.go?type=gene&acc=26249,,,26249,KLHL3,10116,Rattus norvegicus (Norway rat),Gentamicins results in decreased expression of KLHL3 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
136,397553,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,401265.0,KLHL31,https://ctdbase.org/detail.go?type=gene&acc=401265,,,401265,KLHL31,10116,Rattus norvegicus (Norway rat),Gentamicins results in increased expression of KLHL31 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
137,400963,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,3239.0,HOXD13,https://ctdbase.org/detail.go?type=gene&acc=3239,,,3239,HOXD13,10116,Rattus norvegicus (Norway rat),Gentamicins results in decreased expression of HOXD13 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
138,400964,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,3232.0,HOXD3,https://ctdbase.org/detail.go?type=gene&acc=3232,,,3232,HOXD3,10116,Rattus norvegicus (Norway rat),Gentamicins results in decreased expression of HOXD3 mRNA,,,PMID:22061828,https://www.ncbi.nlm.nih.gov/pubmed/22061828,22061828,,
139,400965,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,3235.0,HOXD9,https://ctdbase.org/detail.go?type=gene&acc=3235,,,3235,HOXD9,10116,Rattus norvegicus (Norway rat),Gentamicins results in decreased expression of HOXD9 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
140,400966,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,3240.0,HP,https://ctdbase.org/detail.go?type=gene&acc=3240,,,3240,HP,10116,Rattus norvegicus (Norway rat),[ampicillin co-treated with neomycin co-treated with gentamicins co-treated with metronidazole co-treated with vancomycin] results in increased expression of HP protein,,,PMID:30545405,https://www.ncbi.nlm.nih.gov/pubmed/30545405,30545405,,
141,400967,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,50809.0,HP1BP3,https://ctdbase.org/detail.go?type=gene&acc=50809,,,50809,HP1BP3,10116,Rattus norvegicus (Norway rat),Gentamicins results in decreased expression of HP1BP3 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
142,400968,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,3208.0,HPCA,https://ctdbase.org/detail.go?type=gene&acc=3208,,,3208,HPCA,10116,Rattus norvegicus (Norway rat),Gentamicins results in decreased expression of HPCA mRNA,,,PMID:22061828,https://www.ncbi.nlm.nih.gov/pubmed/22061828,22061828,,
143,393795,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,9245.0,GCNT3,https://ctdbase.org/detail.go?type=gene&acc=9245,,,9245,GCNT3,10116,Rattus norvegicus (Norway rat),Indole-3-carbinol affects the expression of GCNT3 mRNA,,,PMID:21396975,https://www.ncbi.nlm.nih.gov/pubmed/21396975,21396975,,
144,393796,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,9518.0,GDF15,https://ctdbase.org/detail.go?type=gene&acc=9518,,,9518,GDF15,9606,Homo sapiens (human),Indole-3-carbinol results in increased expression of gdf15|[indole-3-carbinol co-treated with resveratrol] results in increased expression of GDF15,,,PMID:15670751,https://www.ncbi.nlm.nih.gov/pubmed/15670751,15670751,,
145,394955,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,2941.0,GSTA4,https://ctdbase.org/detail.go?type=gene&acc=2941,,,2941,GSTA4,10116,Rattus norvegicus (Norway rat),Indole-3-carbinol affects the expression of GSTA4 mRNA,,,PMID:21396975,https://www.ncbi.nlm.nih.gov/pubmed/21396975,21396975,,
146,394956,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,2941.0,GSTA4,https://ctdbase.org/detail.go?type=gene&acc=2941,,,2941,GSTA4,10116,Rattus norvegicus (Norway rat),Indole-3-carbinol results in increased expression of GSTA4 protein,,,PMID:9794803,https://www.ncbi.nlm.nih.gov/pubmed/9794803,9794803,,
147,394957,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,221357.0,GSTA5,https://ctdbase.org/detail.go?type=gene&acc=221357,,,221357,GSTA5,10116,Rattus norvegicus (Norway rat),[indole-3-carbinol co-treated with diethylnitrosamine co-treated with acetylcysteine] results in increased expression of GSTA5 mrna|[indole-3-carbinol co-treated with diethylnitrosamine] results in increased expression of GSTA5 mrna|acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with diethylnitrosamine] results in increased expression of GSTA5 mrna],,,PMID:22129741,https://www.ncbi.nlm.nih.gov/pubmed/22129741,22129741,,
148,394958,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,221357.0,GSTA5,https://ctdbase.org/detail.go?type=gene&acc=221357,,,221357,GSTA5,10116,Rattus norvegicus (Norway rat),Indole-3-carbinol affects the expression of GSTA5 mRNA,,,PMID:21396975,https://www.ncbi.nlm.nih.gov/pubmed/21396975,21396975,,
149,394959,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,221357.0,GSTA5,https://ctdbase.org/detail.go?type=gene&acc=221357,,,221357,GSTA5,10116,Rattus norvegicus (Norway rat),Indole-3-carbinol results in increased expression of GSTA5 mrna|[indole-3-carbinol co-treated with 1-cyano-2-hydroxy-3-butene] results in increased expression of GSTA5 mrna|[indole-3-carbinol co-treated with 1-cyano-2-hydroxy-3-butene] results in increased expression of GSTA5 protein,,,PMID:11446830,https://www.ncbi.nlm.nih.gov/pubmed/11446830,11446830,,
150,394960,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,221357.0,GSTA5,https://ctdbase.org/detail.go?type=gene&acc=221357,,,221357,GSTA5,10116,Rattus norvegicus (Norway rat),Indole-3-carbinol results in increased activity of GSTA5 protein,,,PMID:9328168,https://www.ncbi.nlm.nih.gov/pubmed/9328168,9328168,,
151,394961,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,221357.0,GSTA5,https://ctdbase.org/detail.go?type=gene&acc=221357,,,221357,GSTA5,10116,Rattus norvegicus (Norway rat),Indole-3-carbinol results in increased expression of GSTA5,,,PMID:9806166,https://www.ncbi.nlm.nih.gov/pubmed/9806166,9806166,,
152,394962,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,221357.0,GSTA5,https://ctdbase.org/detail.go?type=gene&acc=221357,,,221357,GSTA5,10116,Rattus norvegicus (Norway rat),Indole-3-carbinol results in increased expression of GSTA5 protein,,,PMID:11446830|PMID:9794803,https://www.ncbi.nlm.nih.gov/pubmed/11446830|https://www.ncbi.nlm.nih.gov/pubmed/9794803,11446830|9794803,,
153,394963,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,48337.0,GSTD4,https://ctdbase.org/detail.go?type=gene&acc=48337,,,48337,GstD4,69820,Spodoptera litura,Indole-3-carbinol results in increased expression of GSTD4 mRNA,,,PMID:29749087,https://www.ncbi.nlm.nih.gov/pubmed/29749087,29749087,,
154,393941,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,11051.0,NUDT21,https://ctdbase.org/detail.go?type=gene&acc=11051,,,11051,NUDT21,90988,Pimephales promelas (fathead minnow),Indomethacin results in increased expression of NUDT21 mRNA,,,PMID:28201806,https://www.ncbi.nlm.nih.gov/pubmed/28201806,28201806,,
155,393942,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,11165.0,NUDT3,https://ctdbase.org/detail.go?type=gene&acc=11165,,,11165,NUDT3,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of NUDT3 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
156,396324,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,142.0,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Indomethacin promotes the reaction [deferoxamine results in increased cleavage of PARP1 protein],,,PMID:21882223,https://www.ncbi.nlm.nih.gov/pubmed/21882223,21882223,,
157,396325,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,142.0,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Indomethacin promotes the reaction [LTA protein results in increased cleavage of PARP1 protein],,,PMID:17873517,https://www.ncbi.nlm.nih.gov/pubmed/17873517,17873517,,
158,396326,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,142.0,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Indomethacin results in increased cleavage of PARP1 protein,,,PMID:11532860|PMID:12663503|PMID:15804060|PMID:15812552|PMID:21400612,https://www.ncbi.nlm.nih.gov/pubmed/11532860|https://www.ncbi.nlm.nih.gov/pubmed/12663503|https://www.ncbi.nlm.nih.gov/pubmed/15804060|https://www.ncbi.nlm.nih.gov/pubmed/15812552|https://www.ncbi.nlm.nih.gov/pubmed/21400612,11532860|12663503|15804060|15812552|21400612,,
159,396327,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,553633.0,PARP12B,https://ctdbase.org/detail.go?type=gene&acc=553633,,,553633,parp12b,90988,Pimephales promelas (fathead minnow),Indomethacin results in increased expression of PARP12B mRNA,,,PMID:28201806,https://www.ncbi.nlm.nih.gov/pubmed/28201806,28201806,,
160,397554,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,8566.0,PDXK,https://ctdbase.org/detail.go?type=gene&acc=8566,,,8566,PDXK,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of PDXK mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in decreased expression of PDXK mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
161,397555,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,118987.0,PDZD8,https://ctdbase.org/detail.go?type=gene&acc=118987,,,118987,PDZD8,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of PDZD8 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
162,397556,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,23024.0,PDZRN3,https://ctdbase.org/detail.go?type=gene&acc=23024,,,23024,PDZRN3,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of PDZRN3 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
163,397860,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,562861.0,PLEKHG5A,https://ctdbase.org/detail.go?type=gene&acc=562861,,,562861,plekhg5a,90988,Pimephales promelas (fathead minnow),Indomethacin results in decreased expression of PLEKHG5A mRNA,,,PMID:28201806,https://www.ncbi.nlm.nih.gov/pubmed/28201806,28201806,,
164,397861,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,5194.0,PEX13,https://ctdbase.org/detail.go?type=gene&acc=5194,,,5194,PEX13,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of PEX13 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of PEX13 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
165,397862,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,5194.0,PEX13,https://ctdbase.org/detail.go?type=gene&acc=5194,,,5194,PEX13,10116,Rattus norvegicus (Norway rat),Indomethacin results in decreased expression of PEX13 mRNA,,,PMID:36868495,https://www.ncbi.nlm.nih.gov/pubmed/36868495,36868495,,
166,397863,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,9409.0,PEX16,https://ctdbase.org/detail.go?type=gene&acc=9409,,,9409,PEX16,90988,Pimephales promelas (fathead minnow),Indomethacin results in increased expression of PEX16 mRNA,,,PMID:28201806,https://www.ncbi.nlm.nih.gov/pubmed/28201806,28201806,,
167,397864,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,5824.0,PEX19,https://ctdbase.org/detail.go?type=gene&acc=5824,,,5824,PEX19,90988,Pimephales promelas (fathead minnow),Indomethacin results in increased expression of PEX19 mRNA,,,PMID:28201806,https://www.ncbi.nlm.nih.gov/pubmed/28201806,28201806,,
168,395128,3821,Comparative Toxicogenomics Database (CTD),Ketamine,D007649,Ketamine,https://ctdbase.org/detail.go?type=chem&acc=D007649,26136.0,TES,https://ctdbase.org/detail.go?type=gene&acc=26136,,,26136,TES,10116,Rattus norvegicus (Norway rat),Ketamine results in decreased expression of TES mRNA,,,PMID:20080153,https://www.ncbi.nlm.nih.gov/pubmed/20080153,20080153,,
169,396319,3821,Comparative Toxicogenomics Database (CTD),Ketamine,D007649,Ketamine,https://ctdbase.org/detail.go?type=chem&acc=D007649,340348.0,TSPAN33,https://ctdbase.org/detail.go?type=gene&acc=340348,,,340348,TSPAN33,10116,Rattus norvegicus (Norway rat),Ketamine results in increased expression of TSPAN33 mRNA,,,PMID:20080153,https://www.ncbi.nlm.nih.gov/pubmed/20080153,20080153,,
170,396320,3821,Comparative Toxicogenomics Database (CTD),Ketamine,D007649,Ketamine,https://ctdbase.org/detail.go?type=chem&acc=D007649,706.0,TSPO,https://ctdbase.org/detail.go?type=gene&acc=706,,,706,TSPO,10116,Rattus norvegicus (Norway rat),[ketamine co-treated with midazolam co-treated with valproic acid] inhibits the reaction [[sarin co-treated with [atropine co-treated with trimethylene-bis(4-hydroxyiminomethylpyridinium)]] results in increased expression of TSPO protein],,,PMID:33823148,https://www.ncbi.nlm.nih.gov/pubmed/33823148,33823148,,
171,396321,3821,Comparative Toxicogenomics Database (CTD),Ketamine,D007649,Ketamine,https://ctdbase.org/detail.go?type=chem&acc=D007649,151613.0,TTC14,https://ctdbase.org/detail.go?type=gene&acc=151613,,,151613,TTC14,10116,Rattus norvegicus (Norway rat),Ketamine results in decreased expression of TTC14 mRNA,,,PMID:20080153,https://www.ncbi.nlm.nih.gov/pubmed/20080153,20080153,,
172,396322,3821,Comparative Toxicogenomics Database (CTD),Ketamine,D007649,Ketamine,https://ctdbase.org/detail.go?type=chem&acc=D007649,79809.0,TTC21B,https://ctdbase.org/detail.go?type=gene&acc=79809,,,79809,TTC21B,10116,Rattus norvegicus (Norway rat),Ketamine results in decreased expression of TTC21B mRNA,,,PMID:20080153,https://www.ncbi.nlm.nih.gov/pubmed/20080153,20080153,,
173,396323,3821,Comparative Toxicogenomics Database (CTD),Ketamine,D007649,Ketamine,https://ctdbase.org/detail.go?type=chem&acc=D007649,25809.0,TTLL1,https://ctdbase.org/detail.go?type=gene&acc=25809,,,25809,TTLL1,10116,Rattus norvegicus (Norway rat),Ketamine results in decreased expression of TTLL1 mRNA,,,PMID:20080153,https://www.ncbi.nlm.nih.gov/pubmed/20080153,20080153,,
174,394111,3840,Comparative Toxicogenomics Database (CTD),Kojic acid,C011890,kojic acid,https://ctdbase.org/detail.go?type=chem&acc=C011890,84225.0,ZMYND15,https://ctdbase.org/detail.go?type=gene&acc=84225,,,84225,ZMYND15,9606,Homo sapiens (human),Kojic acid results in decreased expression of ZMYND15 mRNA,,,PMID:16595896,https://www.ncbi.nlm.nih.gov/pubmed/16595896,16595896,,
175,394112,3840,Comparative Toxicogenomics Database (CTD),Kojic acid,C011890,kojic acid,https://ctdbase.org/detail.go?type=chem&acc=C011890,7705.0,ZNF146,https://ctdbase.org/detail.go?type=gene&acc=7705,,,7705,ZNF146,9606,Homo sapiens (human),Kojic acid results in decreased expression of ZNF146 mRNA,,,PMID:16595896,https://www.ncbi.nlm.nih.gov/pubmed/16595896,16595896,,
176,395129,3869,Comparative Toxicogenomics Database (CTD),Labetalol,D007741,Labetalol,https://ctdbase.org/detail.go?type=chem&acc=D007741,183.0,AGT,https://ctdbase.org/detail.go?type=gene&acc=183,,,183,AGT,9606,Homo sapiens (human),Labetalol results in decreased expression of AGT protein,,,PMID:14627,https://www.ncbi.nlm.nih.gov/pubmed/14627,14627,,
177,395130,3869,Comparative Toxicogenomics Database (CTD),Labetalol,D007741,Labetalol,https://ctdbase.org/detail.go?type=chem&acc=D007741,551.0,AVP,https://ctdbase.org/detail.go?type=gene&acc=551,,,551,AVP,9606,Homo sapiens (human),[labetalol co-treated with isoflurane] results in increased expression of AVP protein,,,PMID:1897344,https://www.ncbi.nlm.nih.gov/pubmed/1897344,1897344,,
178,395131,3869,Comparative Toxicogenomics Database (CTD),Labetalol,D007741,Labetalol,https://ctdbase.org/detail.go?type=chem&acc=D007741,5594.0,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594,MAPK1,9606,Homo sapiens (human),[labetalol binds to ADRB2 protein] which results in increased phosphorylation of MAPK1 protein,,,PMID:17925438,https://www.ncbi.nlm.nih.gov/pubmed/17925438,17925438,,
179,395132,3869,Comparative Toxicogenomics Database (CTD),Labetalol,D007741,Labetalol,https://ctdbase.org/detail.go?type=chem&acc=D007741,5595.0,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595,MAPK3,9606,Homo sapiens (human),[labetalol binds to ADRB2 protein] which results in increased phosphorylation of MAPK3 protein,,,PMID:17925438,https://www.ncbi.nlm.nih.gov/pubmed/17925438,17925438,,
180,395133,3869,Comparative Toxicogenomics Database (CTD),Labetalol,D007741,Labetalol,https://ctdbase.org/detail.go?type=chem&acc=D007741,4878.0,NPPA,https://ctdbase.org/detail.go?type=gene&acc=4878,,,4878,NPPA,9606,Homo sapiens (human),Labetalol results in decreased activity of NPPA protein,,,PMID:2524958,https://www.ncbi.nlm.nih.gov/pubmed/2524958,2524958,,
181,395134,3869,Comparative Toxicogenomics Database (CTD),Labetalol,D007741,Labetalol,https://ctdbase.org/detail.go?type=chem&acc=D007741,5617.0,PRL,https://ctdbase.org/detail.go?type=gene&acc=5617,,,5617,PRL,9606,Homo sapiens (human),"Labetalol results in increased expression of PRL protein|carbidopa, levodopa drug combination inhibits the reaction [labetalol results in increased expression of PRL protein]",,,PMID:7105431,https://www.ncbi.nlm.nih.gov/pubmed/7105431,7105431,,
182,395135,3869,Comparative Toxicogenomics Database (CTD),Labetalol,D007741,Labetalol,https://ctdbase.org/detail.go?type=chem&acc=D007741,5972.0,REN,https://ctdbase.org/detail.go?type=gene&acc=5972,,,5972,REN,9606,Homo sapiens (human),[labetalol co-treated with isoflurane] results in increased expression of REN protein,,,PMID:1897344,https://www.ncbi.nlm.nih.gov/pubmed/1897344,1897344,,
183,394435,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,85458.0,DIXDC1,https://ctdbase.org/detail.go?type=gene&acc=85458,,,85458,DIXDC1,9606,Homo sapiens (human),Leflunomide results in increased expression of DIXDC1 mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
184,394436,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,22943.0,DKK1,https://ctdbase.org/detail.go?type=gene&acc=22943,,,22943,DKK1,9606,Homo sapiens (human),Leflunomide results in decreased expression of DKK1 mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
185,394437,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,10395.0,DLC1,https://ctdbase.org/detail.go?type=gene&acc=10395,,,10395,DLC1,9606,Homo sapiens (human),Leflunomide results in increased expression of DLC1 mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
186,394438,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,8847.0,DLEU2,https://ctdbase.org/detail.go?type=gene&acc=8847,,,8847,DLEU2,9606,Homo sapiens (human),Leflunomide results in decreased expression of DLEU2 mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
187,394439,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,9787.0,DLGAP5,https://ctdbase.org/detail.go?type=gene&acc=9787,,,9787,DLGAP5,9606,Homo sapiens (human),Leflunomide results in decreased expression of DLGAP5 mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
188,394440,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,9787.0,DLGAP5,https://ctdbase.org/detail.go?type=gene&acc=9787,,,9787,DLGAP5,10116,Rattus norvegicus (Norway rat),Leflunomide results in decreased expression of DLGAP5 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
189,394441,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,54567.0,DLL4,https://ctdbase.org/detail.go?type=gene&acc=54567,,,54567,DLL4,9606,Homo sapiens (human),Leflunomide results in increased expression of DLL4 mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
190,394442,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,1750.0,DLX6,https://ctdbase.org/detail.go?type=gene&acc=1750,,,1750,DLX6,9606,Homo sapiens (human),Leflunomide results in decreased expression of DLX6 mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
191,394443,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,29958.0,DMGDH,https://ctdbase.org/detail.go?type=gene&acc=29958,,,29958,DMGDH,10116,Rattus norvegicus (Norway rat),Leflunomide results in increased expression of DMGDH mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
192,395810,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,8726.0,EED,https://ctdbase.org/detail.go?type=gene&acc=8726,,,8726,EED,9606,Homo sapiens (human),Leflunomide results in decreased expression of EED mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
193,395811,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,25895.0,EEF1AKMT3,https://ctdbase.org/detail.go?type=gene&acc=25895,,,25895,EEF1AKMT3,9606,Homo sapiens (human),Leflunomide results in decreased expression of EEF1AKMT3 mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
194,395812,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,29904.0,EEF2K,https://ctdbase.org/detail.go?type=gene&acc=29904,,,29904,EEF2K,9606,Homo sapiens (human),Leflunomide results in decreased expression of EEF2K mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
195,395813,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,80820.0,EEPD1,https://ctdbase.org/detail.go?type=gene&acc=80820,,,80820,EEPD1,9606,Homo sapiens (human),Leflunomide results in increased expression of EEPD1 mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
196,396848,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,54206.0,ERRFI1,https://ctdbase.org/detail.go?type=gene&acc=54206,,,54206,ERRFI1,9606,Homo sapiens (human),Leflunomide results in increased expression of ERRFI1 mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
197,396849,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,114799.0,ESCO1,https://ctdbase.org/detail.go?type=gene&acc=114799,,,114799,ESCO1,9606,Homo sapiens (human),Leflunomide results in increased expression of ESCO1 mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
198,396850,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,51575.0,ESF1,https://ctdbase.org/detail.go?type=gene&acc=51575,,,51575,ESF1,9606,Homo sapiens (human),Leflunomide results in increased expression of ESF1 mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
199,396851,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,9700.0,ESPL1,https://ctdbase.org/detail.go?type=gene&acc=9700,,,9700,ESPL1,9606,Homo sapiens (human),Leflunomide results in decreased expression of ESPL1 mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
200,396852,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,23474.0,ETHE1,https://ctdbase.org/detail.go?type=gene&acc=23474,,,23474,ETHE1,10116,Rattus norvegicus (Norway rat),Leflunomide results in decreased expression of ETHE1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
201,396174,3957,Comparative Toxicogenomics Database (CTD),Loratadine,D017336,Loratadine,https://ctdbase.org/detail.go?type=chem&acc=D017336,367.0,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367,AR,10090,Mus musculus (house mouse),Loratadine results in increased expression of AR mRNA,,,PMID:16407038,https://www.ncbi.nlm.nih.gov/pubmed/16407038,16407038,,
202,396175,3957,Comparative Toxicogenomics Database (CTD),Loratadine,D017336,Loratadine,https://ctdbase.org/detail.go?type=chem&acc=D017336,440.0,ASNS,https://ctdbase.org/detail.go?type=gene&acc=440,,,440,ASNS,9606,Homo sapiens (human),Loratadine results in increased expression of ASNS mRNA,,,PMID:15342952|PMID:17567588,https://www.ncbi.nlm.nih.gov/pubmed/15342952|https://www.ncbi.nlm.nih.gov/pubmed/17567588,15342952|17567588,,
203,396176,3957,Comparative Toxicogenomics Database (CTD),Loratadine,D017336,Loratadine,https://ctdbase.org/detail.go?type=chem&acc=D017336,836.0,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,9615,Canis lupus familiaris (dog),Midostaurin promotes the reaction [loratadine results in increased activity of CASP3 protein]|loratadine results in increased cleavage of CASP3 protein|loratadine results in increased activity of CASP3 protein|dasatinib promotes the reaction [loratadine results in increased activity of CASP3 protein],,,PMID:20570632,https://www.ncbi.nlm.nih.gov/pubmed/20570632,20570632,,
204,396177,3957,Comparative Toxicogenomics Database (CTD),Loratadine,D017336,Loratadine,https://ctdbase.org/detail.go?type=chem&acc=D017336,836.0,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,9606,Homo sapiens (human),Loratadine results in increased activity of CASP3 protein,,,PMID:20570632|PMID:22700542,https://www.ncbi.nlm.nih.gov/pubmed/20570632|https://www.ncbi.nlm.nih.gov/pubmed/22700542,20570632|22700542,,
205,396178,3957,Comparative Toxicogenomics Database (CTD),Loratadine,D017336,Loratadine,https://ctdbase.org/detail.go?type=chem&acc=D017336,836.0,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,9606,Homo sapiens (human),Palmitic acid promotes the reaction [loratadine results in increased activity of CASP3 protein],,,PMID:22700542,https://www.ncbi.nlm.nih.gov/pubmed/22700542,22700542,,
206,396179,3957,Comparative Toxicogenomics Database (CTD),Loratadine,D017336,Loratadine,https://ctdbase.org/detail.go?type=chem&acc=D017336,840.0,CASP7,https://ctdbase.org/detail.go?type=gene&acc=840,,,840,CASP7,9606,Homo sapiens (human),Loratadine results in increased activity of CASP7 protein|palmitic acid promotes the reaction [loratadine results in increased activity of CASP7 protein],,,PMID:22700542,https://www.ncbi.nlm.nih.gov/pubmed/22700542,22700542,,
207,396180,3957,Comparative Toxicogenomics Database (CTD),Loratadine,D017336,Loratadine,https://ctdbase.org/detail.go?type=chem&acc=D017336,841.0,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841,CASP8,9606,Homo sapiens (human),Loratadine results in increased cleavage of CASP8 protein,,,PMID:20570632,https://www.ncbi.nlm.nih.gov/pubmed/20570632,20570632,,
208,397173,3973,BindingDB,2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,12915,2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12915,2107.0,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2107,P42338,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",5291,PIK3CB,9606,Homo sapiens (human),,IC50 (nM),340.0,PMID:17601739|DOI:10.1016/j.bmc.2007.05.070,https://www.ncbi.nlm.nih.gov/pubmed/17601739|https://doi.org/10.1016/j.bmc.2007.05.070,17601739,10.1016/j.bmc.2007.05.070,
209,397174,3973,BindingDB,2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,12915,2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12915,2113.0,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2113,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform ",5294,PIK3CG,9606,Homo sapiens (human),,IC50 (nM),1600.0,PMID:17601739|DOI:10.1016/j.bmc.2007.05.070,https://www.ncbi.nlm.nih.gov/pubmed/17601739|https://doi.org/10.1016/j.bmc.2007.05.070,17601739,10.1016/j.bmc.2007.05.070,
210,397175,3973,BindingDB,2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,12915,2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12915,2762.0,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2762,O00750,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta,5287,PIK3C2B,9606,Homo sapiens (human),,IC50 (nM),2100.0,PMID:17601739|DOI:10.1016/j.bmc.2007.05.070,https://www.ncbi.nlm.nih.gov/pubmed/17601739|https://doi.org/10.1016/j.bmc.2007.05.070,17601739,10.1016/j.bmc.2007.05.070,
211,397176,3973,BindingDB,2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,12915,2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12915,1622.0,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1622,P42336,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",5290,PIK3CA,9606,Homo sapiens (human),,IC50 (nM),630.0,PMID:17049248|DOI:10.1016/j.bmc.2006.09.047,https://www.ncbi.nlm.nih.gov/pubmed/17049248|https://doi.org/10.1016/j.bmc.2006.09.047,17049248,10.1016/j.bmc.2006.09.047,
212,397177,3973,BindingDB,2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,12915,2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12915,2107.0,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2107,P42338,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",5291,PIK3CB,9606,Homo sapiens (human),,IC50 (nM),340.0,PMID:17049248|DOI:10.1016/j.bmc.2006.09.047,https://www.ncbi.nlm.nih.gov/pubmed/17049248|https://doi.org/10.1016/j.bmc.2006.09.047,17049248,10.1016/j.bmc.2006.09.047,
213,397178,3973,BindingDB,2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,12915,2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12915,2113.0,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2113,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform ",5294,PIK3CG,9606,Homo sapiens (human),,IC50 (nM),1600.0,PMID:17049248|DOI:10.1016/j.bmc.2006.09.047,https://www.ncbi.nlm.nih.gov/pubmed/17049248|https://doi.org/10.1016/j.bmc.2006.09.047,17049248,10.1016/j.bmc.2006.09.047,
214,397179,3973,BindingDB,2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,12915,2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12915,2762.0,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2762,O00750,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta,5287,PIK3C2B,9606,Homo sapiens (human),,IC50 (nM),2100.0,PMID:17049248|DOI:10.1016/j.bmc.2006.09.047,https://www.ncbi.nlm.nih.gov/pubmed/17049248|https://doi.org/10.1016/j.bmc.2006.09.047,17049248,10.1016/j.bmc.2006.09.047,
215,397342,3973,BindingDB,2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,12915,2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12915,74.0,"Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=74,P27986,Phosphatidylinositol 3-kinase regulatory subunit alpha,5295,PIK3R1,9606,Homo sapiens (human),,IC50 (nM),5700.0,PMID:17172449|DOI:10.1073/pnas.0606956103,https://www.ncbi.nlm.nih.gov/pubmed/17172449|https://doi.org/10.1073/pnas.0606956103,17172449,10.1073/pnas.0606956103,
216,397343,3973,BindingDB,2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,12915,2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12915,2113.0,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2113,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform ",5294,PIK3CG,9606,Homo sapiens (human),,IC50 (nM),1400.0,PMID:11090628|DOI:10.1016/s1097-2765(05)00089-4,https://www.ncbi.nlm.nih.gov/pubmed/11090628|https://doi.org/10.1016/s1097-2765(05)00089-4,11090628,10.1016/s1097-2765(05)00089-4,
217,397344,3976,Drug Gene Interaction database (DGIdb),"6-Anilino-5,8-quinolinedione",,CHEMBL:CHEMBL312487,https://www.dgidb.org/drugs/chembl:CHEMBL312487,,MAPT,https://www.dgidb.org/genes/hgnc:6893,,,4137,MAPT,9606,Homo sapiens (human),,,,,,,,
218,397345,3998,BindingDB,Mafenide,10860,4-(aminomethyl)benzene-1-sulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10860,1192.0,Carbonic anhydrase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1192,P00915,Carbonic anhydrase 1,759,CA1,9606,Homo sapiens (human),,Ki (nM),41910.0,PMID:21985426|DOI:10.3109/14756366.2011.614607,https://www.ncbi.nlm.nih.gov/pubmed/21985426|https://doi.org/10.3109/14756366.2011.614607,21985426,10.3109/14756366.2011.614607,
219,397859,4030,Comparative Toxicogenomics Database (CTD),Mebendazole,D008463,Mebendazole,https://ctdbase.org/detail.go?type=chem&acc=D008463,836.0,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,9606,Homo sapiens (human),Mebendazole results in increased activity of CASP3 protein,,,PMID:37473966,https://www.ncbi.nlm.nih.gov/pubmed/37473966,37473966,,
220,370643,4506,Comparative Toxicogenomics Database (CTD),Nitrazepam,D009567,Nitrazepam,https://ctdbase.org/detail.go?type=chem&acc=D009567,1109.0,AKR1C4,https://ctdbase.org/detail.go?type=gene&acc=1109,,,1109,AKR1C4,9606,Homo sapiens (human),Nitrazepam results in decreased activity of AKR1C4 protein,,,PMID:11995921,https://www.ncbi.nlm.nih.gov/pubmed/11995921,11995921,,
221,370644,4506,Comparative Toxicogenomics Database (CTD),Nitrazepam,D009567,Nitrazepam,https://ctdbase.org/detail.go?type=chem&acc=D009567,836.0,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,9606,Homo sapiens (human),CYP3A4 protein affects the reaction [nitrazepam results in increased activity of CASP3 protein],,,PMID:19005028,https://www.ncbi.nlm.nih.gov/pubmed/19005028,19005028,,
222,370645,4506,Comparative Toxicogenomics Database (CTD),Nitrazepam,D009567,Nitrazepam,https://ctdbase.org/detail.go?type=chem&acc=D009567,840.0,CASP7,https://ctdbase.org/detail.go?type=gene&acc=840,,,840,CASP7,9606,Homo sapiens (human),CYP3A4 protein affects the reaction [nitrazepam results in increased activity of CASP7 protein],,,PMID:19005028,https://www.ncbi.nlm.nih.gov/pubmed/19005028,19005028,,
223,370646,4506,Comparative Toxicogenomics Database (CTD),Nitrazepam,D009567,Nitrazepam,https://ctdbase.org/detail.go?type=chem&acc=D009567,1576.0,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576,CYP3A4,9606,Homo sapiens (human),CYP3A4 protein affects the reaction [nitrazepam results in increased activity of CASP3 protein]|cyp3a4 protein affects the reaction [nitrazepam results in increased activity of CASP7 protein]|cyp3a4 protein results in increased metabolism of and results in increased activity of nitrazepam,,,PMID:19005028,https://www.ncbi.nlm.nih.gov/pubmed/19005028,19005028,,
224,441617,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,249.0,ALPL,https://ctdbase.org/detail.go?type=gene&acc=249,,,249,ALPL,9606,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [cadmium chloride results in decreased expression of ALPL mrna],,,PMID:22019892,https://www.ncbi.nlm.nih.gov/pubmed/22019892,22019892,,
225,474461,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,5921.0,RASA1,https://ctdbase.org/detail.go?type=gene&acc=5921,,,5921,RASA1,10090,Mus musculus (house mouse),Phenobarbital results in decreased expression of RASA1 mRNA,,,PMID:23091169,https://www.ncbi.nlm.nih.gov/pubmed/23091169,23091169,,
226,397346,5213,Comparative Toxicogenomics Database (CTD),Silymarin,D012838,Silymarin,https://ctdbase.org/detail.go?type=chem&acc=D012838,834.0,CASP1,https://ctdbase.org/detail.go?type=gene&acc=834,,,834,CASP1,9606,Homo sapiens (human),[essential 303 forte co-treated with silymarin] affects the activity of CASP1 protein|[essential 303 forte co-treated with silymarin co-treated with melatonin analog] affects the activity of CASP1 protein,,,PMID:25903262,https://www.ncbi.nlm.nih.gov/pubmed/25903262,25903262,,
227,397347,5213,Comparative Toxicogenomics Database (CTD),Silymarin,D012838,Silymarin,https://ctdbase.org/detail.go?type=chem&acc=D012838,834.0,CASP1,https://ctdbase.org/detail.go?type=gene&acc=834,,,834,CASP1,10090,Mus musculus (house mouse),Silymarin inhibits the reaction [[maneb co-treated with paraquat] results in increased expression of CASP1 mrna],,,PMID:23963992,https://www.ncbi.nlm.nih.gov/pubmed/23963992,23963992,,
228,397348,5213,Comparative Toxicogenomics Database (CTD),Silymarin,D012838,Silymarin,https://ctdbase.org/detail.go?type=chem&acc=D012838,834.0,CASP1,https://ctdbase.org/detail.go?type=gene&acc=834,,,834,CASP1,10090,Mus musculus (house mouse),Silymarin inhibits the reaction [paraquat results in increased expression of CASP1 protein modified form]|silymarin inhibits the reaction [paraquat results in increased expression of CASP1 protein],,,PMID:29054699,https://www.ncbi.nlm.nih.gov/pubmed/29054699,29054699,,
229,397349,5213,Comparative Toxicogenomics Database (CTD),Silymarin,D012838,Silymarin,https://ctdbase.org/detail.go?type=chem&acc=D012838,836.0,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,9606,Homo sapiens (human),[essential 303 forte co-treated with silymarin co-treated with melatonin analog] affects the activity of CASP3 protein,,,PMID:25903262,https://www.ncbi.nlm.nih.gov/pubmed/25903262,25903262,,
230,397350,5213,Comparative Toxicogenomics Database (CTD),Silymarin,D012838,Silymarin,https://ctdbase.org/detail.go?type=chem&acc=D012838,836.0,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,10090,Mus musculus (house mouse),Silymarin inhibits the reaction [[lipopolysaccharides co-treated with galactosamine] results in increased expression of CASP3 protein modified form],,,PMID:20850421,https://www.ncbi.nlm.nih.gov/pubmed/20850421,20850421,,
231,397351,5213,Comparative Toxicogenomics Database (CTD),Silymarin,D012838,Silymarin,https://ctdbase.org/detail.go?type=chem&acc=D012838,836.0,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,10090,Mus musculus (house mouse),Silymarin inhibits the reaction [mercuric chloride results in increased activity of CASP3 protein],,,PMID:15050407,https://www.ncbi.nlm.nih.gov/pubmed/15050407,15050407,,
232,400811,5213,Comparative Toxicogenomics Database (CTD),Silymarin,D012838,Silymarin,https://ctdbase.org/detail.go?type=chem&acc=D012838,3569.0,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569,IL6,10116,Rattus norvegicus (Norway rat),Silymarin inhibits the reaction [[cadmium chloride results in increased abundance of cadmium] which results in increased expression of IL6 protein],,,PMID:36718047,https://www.ncbi.nlm.nih.gov/pubmed/36718047,36718047,,
233,400812,5213,Comparative Toxicogenomics Database (CTD),Silymarin,D012838,Silymarin,https://ctdbase.org/detail.go?type=chem&acc=D012838,3569.0,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569,IL6,10116,Rattus norvegicus (Norway rat),Silymarin inhibits the reaction [ethanol results in increased expression of IL6 mrna],,,PMID:26115886,https://www.ncbi.nlm.nih.gov/pubmed/26115886,26115886,,
234,394270,5258,Comparative Toxicogenomics Database (CTD),Sodium Phenylbutyrate,C075773,4-phenylbutyric acid,https://ctdbase.org/detail.go?type=chem&acc=C075773,1649.0,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649,DDIT3,9606,Homo sapiens (human),4-phenylbutyric acid inhibits the reaction [flavokawain B results in increased expression of DDIT3 protein],,,PMID:30025493,https://www.ncbi.nlm.nih.gov/pubmed/30025493,30025493,,
235,394271,5258,Comparative Toxicogenomics Database (CTD),Sodium Phenylbutyrate,C075773,4-phenylbutyric acid,https://ctdbase.org/detail.go?type=chem&acc=C075773,1649.0,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649,DDIT3,9606,Homo sapiens (human),4-phenylbutyric acid inhibits the reaction [fumonisin B1 results in increased expression of DDIT3 protein],,,PMID:31891755,https://www.ncbi.nlm.nih.gov/pubmed/31891755,31891755,,
236,394272,5258,Comparative Toxicogenomics Database (CTD),Sodium Phenylbutyrate,C075773,4-phenylbutyric acid,https://ctdbase.org/detail.go?type=chem&acc=C075773,1649.0,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649,DDIT3,9606,Homo sapiens (human),4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of and affects the localization of DDIT3 protein],,,PMID:24053669,https://www.ncbi.nlm.nih.gov/pubmed/24053669,24053669,,
237,394273,5258,Comparative Toxicogenomics Database (CTD),Sodium Phenylbutyrate,C075773,4-phenylbutyric acid,https://ctdbase.org/detail.go?type=chem&acc=C075773,1649.0,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649,DDIT3,9606,Homo sapiens (human),4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of DDIT3 protein],,,PMID:36646296,https://www.ncbi.nlm.nih.gov/pubmed/36646296,36646296,,
238,394274,5258,Comparative Toxicogenomics Database (CTD),Sodium Phenylbutyrate,C075773,4-phenylbutyric acid,https://ctdbase.org/detail.go?type=chem&acc=C075773,1649.0,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649,DDIT3,9606,Homo sapiens (human),4-phenylbutyric acid inhibits the reaction [leflunomide results in increased expression of DDIT3 protein],,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
239,394615,5258,Comparative Toxicogenomics Database (CTD),Sodium Phenylbutyrate,C075773,4-phenylbutyric acid,https://ctdbase.org/detail.go?type=chem&acc=C075773,1649.0,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649,DDIT3,10090,Mus musculus (house mouse),4-phenylbutyric acid inhibits the reaction [arsenic trioxide results in increased expression of DDIT3 protein],,,PMID:27638049,https://www.ncbi.nlm.nih.gov/pubmed/27638049,27638049,,
240,394616,5258,Comparative Toxicogenomics Database (CTD),Sodium Phenylbutyrate,C075773,4-phenylbutyric acid,https://ctdbase.org/detail.go?type=chem&acc=C075773,1649.0,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649,DDIT3,10090,Mus musculus (house mouse),4-phenylbutyric acid inhibits the reaction [bilirubin results in increased expression of DDIT3 mrna],,,PMID:27578021,https://www.ncbi.nlm.nih.gov/pubmed/27578021,27578021,,
241,331902,5519,Comparative Toxicogenomics Database (CTD),"N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine",C044387,"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine",https://ctdbase.org/detail.go?type=chem&acc=C044387,79132.0,DHX58,https://ctdbase.org/detail.go?type=gene&acc=79132,,,79132,DHX58,9606,Homo sapiens (human),"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of DHX58 mRNA",,,PMID:12756304,https://www.ncbi.nlm.nih.gov/pubmed/12756304,12756304,,
242,505829,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,139285.0,AMER1,https://ctdbase.org/detail.go?type=gene&acc=139285,,,139285,AMER1,9606,Homo sapiens (human),Urethane results in decreased expression of AMER1 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
243,505830,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,267.0,AMFR,https://ctdbase.org/detail.go?type=gene&acc=267,,,267,AMFR,9606,Homo sapiens (human),Urethane results in increased expression of AMFR mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
244,394103,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,388327.0,C17ORF100,https://ctdbase.org/detail.go?type=gene&acc=388327,,,388327,C17orf100,9606,Homo sapiens (human),Estradiol results in decreased expression of C17ORF100 mRNA,,,PMID:31614463,https://www.ncbi.nlm.nih.gov/pubmed/31614463,31614463,,
245,394104,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,100130311.0,C17ORF107,https://ctdbase.org/detail.go?type=gene&acc=100130311,,,100130311,C17orf107,9606,Homo sapiens (human),Estradiol results in increased expression of C17ORF107 mRNA,,,PMID:31614463,https://www.ncbi.nlm.nih.gov/pubmed/31614463,31614463,,
246,394105,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,124944.0,C17ORF49,https://ctdbase.org/detail.go?type=gene&acc=124944,,,124944,C17orf49,9606,Homo sapiens (human),Estradiol results in decreased expression of C17ORF49 mRNA,,,PMID:23019147,https://www.ncbi.nlm.nih.gov/pubmed/23019147,23019147,,
247,394106,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,497661.0,C18ORF32,https://ctdbase.org/detail.go?type=gene&acc=497661,,,497661,C18orf32,9606,Homo sapiens (human),Estradiol results in decreased expression of C18ORF32 mRNA,,,PMID:23019147,https://www.ncbi.nlm.nih.gov/pubmed/23019147,23019147,,
248,394107,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,497661.0,C18ORF32,https://ctdbase.org/detail.go?type=gene&acc=497661,,,497661,C18orf32,8090,Oryzias latipes (Japanese medaka),Estradiol results in decreased expression of C18ORF32 mRNA,,,PMID:32622090,https://www.ncbi.nlm.nih.gov/pubmed/32622090,32622090,,
249,394108,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,56913.0,C1GALT1,https://ctdbase.org/detail.go?type=gene&acc=56913,,,56913,C1GALT1,10116,Rattus norvegicus (Norway rat),Estradiol results in increased expression of C1GALT1 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
250,394109,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,309145.0,C1H11ORF24,https://ctdbase.org/detail.go?type=gene&acc=309145,,,309145,C1h11orf24,10116,Rattus norvegicus (Norway rat),Estradiol results in increased expression of C1H11ORF24 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
251,394110,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,127518619.0,C1H19ORF67,https://ctdbase.org/detail.go?type=gene&acc=127518619,,,127518619,c1h19orf67,8090,Oryzias latipes (Japanese medaka),Estradiol results in decreased expression of C1H19ORF67 mRNA,,,PMID:32622090,https://www.ncbi.nlm.nih.gov/pubmed/32622090,32622090,,
252,394779,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,388581.0,C1QTNF12,https://ctdbase.org/detail.go?type=gene&acc=388581,,,388581,C1QTNF12,9606,Homo sapiens (human),Estradiol results in decreased expression of C1QTNF12 mRNA,,,PMID:31614463,https://www.ncbi.nlm.nih.gov/pubmed/31614463,31614463,,
253,394780,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,114898.0,C1QTNF2,https://ctdbase.org/detail.go?type=gene&acc=114898,,,114898,C1QTNF2,9606,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in increased expression of C1QTNF2 mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
254,394781,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,114899.0,C1QTNF3,https://ctdbase.org/detail.go?type=gene&acc=114899,,,114899,C1QTNF3,9606,Homo sapiens (human),Estradiol results in decreased expression of C1QTNF3 mRNA,,,PMID:31614463,https://www.ncbi.nlm.nih.gov/pubmed/31614463,31614463,,
255,394782,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,114899.0,C1QTNF3,https://ctdbase.org/detail.go?type=gene&acc=114899,,,114899,C1QTNF3,10090,Mus musculus (house mouse),Estradiol results in increased expression of C1QTNF3 mRNA,,,PMID:19484750,https://www.ncbi.nlm.nih.gov/pubmed/19484750,19484750,,
256,394783,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,570839.0,C1QTNF6B,https://ctdbase.org/detail.go?type=gene&acc=570839,,,570839,c1qtnf6b,8090,Oryzias latipes (Japanese medaka),Estradiol results in increased expression of C1QTNF6B mRNA,,,PMID:32622090,https://www.ncbi.nlm.nih.gov/pubmed/32622090,32622090,,
257,394784,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,114905.0,C1QTNF7,https://ctdbase.org/detail.go?type=gene&acc=114905,,,114905,C1QTNF7,9606,Homo sapiens (human),[estradiol co-treated with progesterone] results in decreased expression of C1QTNF7 mRNA,,,PMID:20660070,https://www.ncbi.nlm.nih.gov/pubmed/20660070,20660070,,
258,394785,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,715.0,C1R,https://ctdbase.org/detail.go?type=gene&acc=715,,,715,C1R,9606,Homo sapiens (human),[estradiol co-treated with bucladesine co-treated with medroxyprogesterone acetate] results in increased expression of C1R mRNA,,,PMID:20823114,https://www.ncbi.nlm.nih.gov/pubmed/20823114,20823114,,
259,394786,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,715.0,C1R,https://ctdbase.org/detail.go?type=gene&acc=715,,,715,C1R,9606,Homo sapiens (human),Estradiol results in increased expression of C1R mrna|[estradiol co-treated with tetrachlorodibenzodioxin] results in decreased expression of C1R mRNA,,,PMID:19619570,https://www.ncbi.nlm.nih.gov/pubmed/19619570,19619570,,
260,394787,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,715.0,C1R,https://ctdbase.org/detail.go?type=gene&acc=715,,,715,C1R,9606,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in decreased expression of C1R mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
261,395664,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,718.0,C3,https://ctdbase.org/detail.go?type=gene&acc=718,,,718,C3,10090,Mus musculus (house mouse),Estradiol results in decreased activity of C3 protein,,,PMID:18615583,https://www.ncbi.nlm.nih.gov/pubmed/18615583,18615583,,
262,396483,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,729.0,C6,https://ctdbase.org/detail.go?type=gene&acc=729,,,729,C6,10116,Rattus norvegicus (Norway rat),Estradiol results in increased expression of C6 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
263,396484,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,647024.0,C6ORF132,https://ctdbase.org/detail.go?type=gene&acc=647024,,,647024,C6orf132,9606,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in decreased expression of C6ORF132 mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
264,396485,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,647024.0,C6ORF132,https://ctdbase.org/detail.go?type=gene&acc=647024,,,647024,C6orf132,9606,Homo sapiens (human),Estradiol results in increased expression of C6ORF132 mRNA,,,PMID:23019147|PMID:31614463,https://www.ncbi.nlm.nih.gov/pubmed/23019147|https://www.ncbi.nlm.nih.gov/pubmed/31614463,23019147|31614463,,
265,396486,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,135398.0,C6ORF141,https://ctdbase.org/detail.go?type=gene&acc=135398,,,135398,C6orf141,9606,Homo sapiens (human),Estradiol results in increased expression of C6ORF141 mRNA,,,PMID:31614463,https://www.ncbi.nlm.nih.gov/pubmed/31614463,31614463,,
266,396487,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,730.0,C7,https://ctdbase.org/detail.go?type=gene&acc=730,,,730,C7,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of C7 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
267,396488,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,730.0,C7,https://ctdbase.org/detail.go?type=gene&acc=730,,,730,C7,10116,Rattus norvegicus (Norway rat),Estradiol results in increased expression of C7 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
268,396489,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,731.0,C8A,https://ctdbase.org/detail.go?type=gene&acc=731,,,731,C8A,7955,Danio rerio (zebrafish),Estradiol results in decreased expression of C8A mRNA,,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
269,396688,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,414919.0,C8ORF82,https://ctdbase.org/detail.go?type=gene&acc=414919,,,414919,C8orf82,9606,Homo sapiens (human),Estradiol results in decreased expression of C8ORF82 mRNA,,,PMID:31614463,https://www.ncbi.nlm.nih.gov/pubmed/31614463,31614463,,
270,396689,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,735.0,C9,https://ctdbase.org/detail.go?type=gene&acc=735,,,735,C9,7955,Danio rerio (zebrafish),Estradiol affects the expression of C9 mRNA,,,PMID:23557687,https://www.ncbi.nlm.nih.gov/pubmed/23557687,23557687,,
271,396690,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,735.0,C9,https://ctdbase.org/detail.go?type=gene&acc=735,,,735,C9,7955,Danio rerio (zebrafish),Estradiol results in decreased expression of C9 mRNA,,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
272,396691,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,735.0,C9,https://ctdbase.org/detail.go?type=gene&acc=735,,,735,C9,8090,Oryzias latipes (Japanese medaka),Estradiol results in decreased expression of C9 mRNA,,,PMID:32622090,https://www.ncbi.nlm.nih.gov/pubmed/32622090,32622090,,
273,396692,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,735.0,C9,https://ctdbase.org/detail.go?type=gene&acc=735,,,735,C9,10116,Rattus norvegicus (Norway rat),Estradiol affects the expression of C9 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
274,396693,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,401546.0,C9ORF152,https://ctdbase.org/detail.go?type=gene&acc=401546,,,401546,C9orf152,9606,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in decreased expression of C9ORF152 mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
275,396694,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,759.0,CA1,https://ctdbase.org/detail.go?type=gene&acc=759,,,759,CA1,10116,Rattus norvegicus (Norway rat),Estradiol results in increased expression of CA1 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
276,396695,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,770.0,CA11,https://ctdbase.org/detail.go?type=gene&acc=770,,,770,CA11,9606,Homo sapiens (human),[estradiol co-treated with tetrachlorodibenzodioxin] results in decreased expression of CA11 mrna|estradiol results in increased expression of CA11 mRNA,,,PMID:19619570,https://www.ncbi.nlm.nih.gov/pubmed/19619570,19619570,,
277,396696,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,770.0,CA11,https://ctdbase.org/detail.go?type=gene&acc=770,,,770,CA11,9606,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in decreased expression of CA11 mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
278,429026,5881,Comparative Toxicogenomics Database (CTD),Prasterone,D003687,Dehydroepiandrosterone,https://ctdbase.org/detail.go?type=chem&acc=D003687,3251.0,HPRT1,https://ctdbase.org/detail.go?type=gene&acc=3251,,,3251,HPRT1,8022,Oncorhynchus mykiss (rainbow trout),Dehydroepiandrosterone results in increased expression of HPRT1 mRNA,,,PMID:18709148,https://www.ncbi.nlm.nih.gov/pubmed/18709148,18709148,,
279,395305,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,316153.0,SULT1C2A,https://ctdbase.org/detail.go?type=gene&acc=316153,,,316153,Sult1c2a,10116,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of SULT1C2A mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
280,395306,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,501084.0,SULT1C2AL1,https://ctdbase.org/detail.go?type=gene&acc=501084,,,501084,Sult1c2al1,10116,Rattus norvegicus (Norway rat),Carbon tetrachloride results in decreased expression of SULT1C2AL1 mrna|schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of SULT1C2AL1 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
281,403924,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,7076.0,TIMP1,https://ctdbase.org/detail.go?type=gene&acc=7076,,,7076,TIMP1,10090,Mus musculus (house mouse),Epigallocatechin gallate inhibits the reaction [carbon tetrachloride results in increased expression of TIMP1 mrna],,,PMID:20438794,https://www.ncbi.nlm.nih.gov/pubmed/20438794,20438794,,
282,403925,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,79073.0,TMEM109,https://ctdbase.org/detail.go?type=gene&acc=79073,,,79073,TMEM109,10090,Mus musculus (house mouse),Carbon tetrachloride results in increased expression of TMEM109 mRNA,,,PMID:31919559,https://www.ncbi.nlm.nih.gov/pubmed/31919559,31919559,,
283,696016,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,51263.0,MRPL30,https://ctdbase.org/detail.go?type=gene&acc=51263,,,51263,MRPL30,10090,Mus musculus (house mouse),Progesterone affects the expression of MRPL30 mRNA,,,PMID:17251523,https://www.ncbi.nlm.nih.gov/pubmed/17251523,17251523,,
284,696017,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,64983.0,MRPL32,https://ctdbase.org/detail.go?type=gene&acc=64983,,,64983,MRPL32,9913,Bos taurus (cattle),Progesterone results in increased expression of MRPL32 mRNA,,,PMID:23018184,https://www.ncbi.nlm.nih.gov/pubmed/23018184,23018184,,
285,696018,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,740.0,MRPL49,https://ctdbase.org/detail.go?type=gene&acc=740,,,740,MRPL49,9606,Homo sapiens (human),[estradiol co-treated with progesterone] results in decreased expression of MRPL49 mRNA,,,PMID:21453500,https://www.ncbi.nlm.nih.gov/pubmed/21453500,21453500,,
286,696019,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,28957.0,MRPS28,https://ctdbase.org/detail.go?type=gene&acc=28957,,,28957,MRPS28,9913,Bos taurus (cattle),Progesterone results in decreased expression of MRPS28 mRNA,,,PMID:23012394,https://www.ncbi.nlm.nih.gov/pubmed/23012394,23012394,,
287,696020,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,28957.0,MRPS28,https://ctdbase.org/detail.go?type=gene&acc=28957,,,28957,MRPS28,9606,Homo sapiens (human),Progesterone results in decreased expression of MRPS28 mRNA,,,PMID:18037150,https://www.ncbi.nlm.nih.gov/pubmed/18037150,18037150,,
288,696021,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,66128.0,MRPS36,https://ctdbase.org/detail.go?type=gene&acc=66128,,,66128,Mrps36,9913,Bos taurus (cattle),Progesterone results in decreased expression of MRPS36 mRNA,,,PMID:19553605|PMID:23018184,https://www.ncbi.nlm.nih.gov/pubmed/19553605|https://www.ncbi.nlm.nih.gov/pubmed/23018184,19553605|23018184,,
289,696022,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,64968.0,MRPS6,https://ctdbase.org/detail.go?type=gene&acc=64968,,,64968,MRPS6,9606,Homo sapiens (human),Progesterone results in increased expression of MRPS6 mRNA,,,PMID:18037150,https://www.ncbi.nlm.nih.gov/pubmed/18037150,18037150,,
290,696023,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,51154.0,MRTO4,https://ctdbase.org/detail.go?type=gene&acc=51154,,,51154,MRTO4,9606,Homo sapiens (human),Progesterone results in decreased expression of MRTO4 mRNA,,,PMID:18037150,https://www.ncbi.nlm.nih.gov/pubmed/18037150,18037150,,
291,696024,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,10943.0,MSL3,https://ctdbase.org/detail.go?type=gene&acc=10943,,,10943,MSL3,9913,Bos taurus (cattle),Progesterone results in increased expression of MSL3 mRNA,,,PMID:23018184,https://www.ncbi.nlm.nih.gov/pubmed/23018184,23018184,,
292,695561,6076,Comparative Toxicogenomics Database (CTD),Adenosine cyclic phosphate,D000242,Cyclic AMP,https://ctdbase.org/detail.go?type=chem&acc=D000242,27115.0,PDE7B,https://ctdbase.org/detail.go?type=gene&acc=27115,,,27115,PDE7B,10090,Mus musculus (house mouse),Papaverine inhibits the reaction [PDE7B protein results in increased hydrolysis of cyclic AMP]|SCH 51866 inhibits the reaction [PDE7B protein results in increased hydrolysis of cyclic AMP],,,PMID:10618442,https://www.ncbi.nlm.nih.gov/pubmed/10618442,10618442,,
293,485678,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,26099.0,SZRD1,https://ctdbase.org/detail.go?type=gene&acc=26099,,,26099,SZRD1,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in decreased expression of SZRD1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
294,485679,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,9287.0,TAAR2,https://ctdbase.org/detail.go?type=gene&acc=9287,,,9287,TAAR2,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in increased methylation of TAAR2 gene,,,PMID:27618143,https://www.ncbi.nlm.nih.gov/pubmed/27618143,27618143,,
295,485680,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,319100.0,TAAR6,https://ctdbase.org/detail.go?type=gene&acc=319100,,,319100,TAAR6,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in increased methylation of TAAR6 gene,,,PMID:27618143,https://www.ncbi.nlm.nih.gov/pubmed/27618143,27618143,,
296,485681,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,215856.0,TAAR7A,https://ctdbase.org/detail.go?type=gene&acc=215856,,,215856,Taar7a,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in increased methylation of TAAR7A gene,,,PMID:27618143,https://www.ncbi.nlm.nih.gov/pubmed/27618143,27618143,,
297,696267,7847,Comparative Toxicogenomics Database (CTD),Acrolein,D000171,Acrolein,https://ctdbase.org/detail.go?type=chem&acc=D000171,8658.0,TNKS,https://ctdbase.org/detail.go?type=gene&acc=8658,,,8658,TNKS,9606,Homo sapiens (human),[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased expression of TNKS mrna|[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased expression of TNKS mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
298,696268,7847,Comparative Toxicogenomics Database (CTD),Acrolein,D000171,Acrolein,https://ctdbase.org/detail.go?type=chem&acc=D000171,8658.0,TNKS,https://ctdbase.org/detail.go?type=gene&acc=8658,,,8658,TNKS,9606,Homo sapiens (human),[acrolein co-treated with methacrylaldehyde co-treated with ozone] results in increased expression of TNKS mRNA,,,PMID:32845096,https://www.ncbi.nlm.nih.gov/pubmed/32845096,32845096,,
299,696269,7847,Comparative Toxicogenomics Database (CTD),Acrolein,D000171,Acrolein,https://ctdbase.org/detail.go?type=chem&acc=D000171,7139.0,TNNT2,https://ctdbase.org/detail.go?type=gene&acc=7139,,,7139,TNNT2,9606,Homo sapiens (human),Acrolein results in decreased expression of TNNT2 mRNA,,,PMID:24211530,https://www.ncbi.nlm.nih.gov/pubmed/24211530,24211530,,
300,696270,7847,Comparative Toxicogenomics Database (CTD),Acrolein,D000171,Acrolein,https://ctdbase.org/detail.go?type=chem&acc=D000171,3842.0,TNPO1,https://ctdbase.org/detail.go?type=gene&acc=3842,,,3842,TNPO1,9606,Homo sapiens (human),[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased oxidation of TNPO1 mrna|[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased oxidation of TNPO1 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
301,1209219,16942,Comparative Toxicogenomics Database (CTD),2-Methylcholine,C044887,beta-methylcholine,https://ctdbase.org/detail.go?type=chem&acc=C044887,6919.0,TCEA2,https://ctdbase.org/detail.go?type=gene&acc=6919,,,6919,TCEA2,9606,Homo sapiens (human),Beta-methylcholine affects the expression of TCEA2 mRNA,,,PMID:21179406,https://www.ncbi.nlm.nih.gov/pubmed/21179406,21179406,,
302,1209220,16942,Comparative Toxicogenomics Database (CTD),2-Methylcholine,C044887,beta-methylcholine,https://ctdbase.org/detail.go?type=chem&acc=C044887,90843.0,TCEAL8,https://ctdbase.org/detail.go?type=gene&acc=90843,,,90843,TCEAL8,9606,Homo sapiens (human),Beta-methylcholine affects the expression of TCEAL8 mRNA,,,PMID:21179406,https://www.ncbi.nlm.nih.gov/pubmed/21179406,21179406,,
303,1208956,18381,Comparative Toxicogenomics Database (CTD),Dicloxacillin,D004009,Dicloxacillin,https://ctdbase.org/detail.go?type=chem&acc=D004009,114548.0,NLRP3,https://ctdbase.org/detail.go?type=gene&acc=114548,,,114548,NLRP3,10090,Mus musculus (house mouse),Dicloxacillin results in increased expression of NLRP3 mRNA,,,PMID:24747151,https://www.ncbi.nlm.nih.gov/pubmed/24747151,24747151,,
304,1208957,18381,Comparative Toxicogenomics Database (CTD),Dicloxacillin,D004009,Dicloxacillin,https://ctdbase.org/detail.go?type=chem&acc=D004009,8856.0,NR1I2,https://ctdbase.org/detail.go?type=gene&acc=8856,,,8856,NR1I2,9606,Homo sapiens (human),Dicloxacillin results in increased activity of NR1I2 protein,,,PMID:25455453,https://www.ncbi.nlm.nih.gov/pubmed/25455453,25455453,,
305,1208958,18381,Comparative Toxicogenomics Database (CTD),Dicloxacillin,D004009,Dicloxacillin,https://ctdbase.org/detail.go?type=chem&acc=D004009,6279.0,S100A8,https://ctdbase.org/detail.go?type=gene&acc=6279,,,6279,S100A8,9606,Homo sapiens (human),Dicloxacillin results in increased expression of S100A8 mRNA,,,PMID:28138970,https://www.ncbi.nlm.nih.gov/pubmed/28138970,28138970,,
306,1208959,18381,Comparative Toxicogenomics Database (CTD),Dicloxacillin,D004009,Dicloxacillin,https://ctdbase.org/detail.go?type=chem&acc=D004009,6279.0,S100A8,https://ctdbase.org/detail.go?type=gene&acc=6279,,,6279,S100A8,10090,Mus musculus (house mouse),Dicloxacillin results in increased expression of S100A8 mRNA,,,PMID:24747151,https://www.ncbi.nlm.nih.gov/pubmed/24747151,24747151,,
307,1208960,18381,Comparative Toxicogenomics Database (CTD),Dicloxacillin,D004009,Dicloxacillin,https://ctdbase.org/detail.go?type=chem&acc=D004009,6280.0,S100A9,https://ctdbase.org/detail.go?type=gene&acc=6280,,,6280,S100A9,10090,Mus musculus (house mouse),Dicloxacillin results in increased expression of S100A9 mRNA,,,PMID:24747151,https://www.ncbi.nlm.nih.gov/pubmed/24747151,24747151,,
308,1256639,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,57585.0,CRAMP1,https://ctdbase.org/detail.go?type=gene&acc=57585,,,57585,CRAMP1,9606,Homo sapiens (human),[acrolein co-treated with methacrylaldehyde co-treated with ozone] results in increased expression of CRAMP1 mRNA,,,PMID:32845096,https://www.ncbi.nlm.nih.gov/pubmed/32845096,32845096,,
309,1256640,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,1384.0,CRAT,https://ctdbase.org/detail.go?type=gene&acc=1384,,,1384,CRAT,10090,Mus musculus (house mouse),Ozone results in decreased expression of CRAT mRNA,,,PMID:12763052,https://www.ncbi.nlm.nih.gov/pubmed/12763052,12763052,,
310,1256641,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,1384.0,CRAT,https://ctdbase.org/detail.go?type=gene&acc=1384,,,1384,CRAT,10116,Rattus norvegicus (Norway rat),[coconut oil co-treated with ozone] results in decreased expression of CRAT mrna|[fish oils co-treated with ozone] results in increased expression of CRAT mrna|ozone inhibits the reaction [olive oil results in decreased expression of CRAT mrna],,,PMID:33217375,https://www.ncbi.nlm.nih.gov/pubmed/33217375,33217375,,
311,1256642,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,1384.0,CRAT,https://ctdbase.org/detail.go?type=gene&acc=1384,,,1384,CRAT,10116,Rattus norvegicus (Norway rat),Ozone results in decreased expression of CRAT mRNA,,,PMID:33217375|PMID:33524448,https://www.ncbi.nlm.nih.gov/pubmed/33217375|https://www.ncbi.nlm.nih.gov/pubmed/33524448,33217375|33524448,,
312,1256643,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,1384.0,CRAT,https://ctdbase.org/detail.go?type=gene&acc=1384,,,1384,CRAT,10116,Rattus norvegicus (Norway rat),Ozone results in increased expression of CRAT mRNA,,,PMID:35737395,https://www.ncbi.nlm.nih.gov/pubmed/35737395,35737395,,
313,1256644,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,92359.0,CRB3,https://ctdbase.org/detail.go?type=gene&acc=92359,,,92359,CRB3,10090,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in increased expression of CRB3 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
314,1256645,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,55669.0,MFN1,https://ctdbase.org/detail.go?type=gene&acc=55669,,,55669,MFN1,9823,Sus scrofa (pig),[cadmium chloride results in increased abundance of cadmium] which results in decreased expression of MFN1 mRNA,,,PMID:33493553|PMID:33592257,https://www.ncbi.nlm.nih.gov/pubmed/33493553|https://www.ncbi.nlm.nih.gov/pubmed/33592257,33493553|33592257,,
315,1209221,25408,Comparative Toxicogenomics Database (CTD),Sodium Dichromate,C016104,sodium bichromate,https://ctdbase.org/detail.go?type=chem&acc=C016104,9173.0,IL1RL1,https://ctdbase.org/detail.go?type=gene&acc=9173,,,9173,IL1RL1,10116,Rattus norvegicus (Norway rat),Sodium bichromate results in increased expression of IL1RL1 mRNA,,,PMID:22561333,https://www.ncbi.nlm.nih.gov/pubmed/22561333,22561333,,
316,1209222,25408,Comparative Toxicogenomics Database (CTD),Sodium Dichromate,C016104,sodium bichromate,https://ctdbase.org/detail.go?type=chem&acc=C016104,3558.0,IL2,https://ctdbase.org/detail.go?type=gene&acc=3558,,,3558,IL2,9606,Homo sapiens (human),Sodium bichromate inhibits the reaction [[ionomycin co-treated with tetradecanoylphorbol acetate] results in increased secretion of IL2 protein],,,PMID:17685462,https://www.ncbi.nlm.nih.gov/pubmed/17685462,17685462,,
317,1208953,26177,Comparative Toxicogenomics Database (CTD),"Tris(1,3-dichloro-2-propyl)phosphate",C016805,"tris(1,3-dichloro-2-propyl)phosphate",https://ctdbase.org/detail.go?type=chem&acc=C016805,55317.0,AP5S1,https://ctdbase.org/detail.go?type=gene&acc=55317,,,55317,AP5S1,9606,Homo sapiens (human),"Tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of AP5S1 mRNA",,,PMID:26179874,https://www.ncbi.nlm.nih.gov/pubmed/26179874,26179874,,
318,1208954,26177,Comparative Toxicogenomics Database (CTD),"Tris(1,3-dichloro-2-propyl)phosphate",C016805,"tris(1,3-dichloro-2-propyl)phosphate",https://ctdbase.org/detail.go?type=chem&acc=C016805,317.0,APAF1,https://ctdbase.org/detail.go?type=gene&acc=317,,,317,APAF1,9606,Homo sapiens (human),"Tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of APAF1 mRNA",,,PMID:26179874,https://www.ncbi.nlm.nih.gov/pubmed/26179874,26179874,,
319,1208955,26177,Comparative Toxicogenomics Database (CTD),"Tris(1,3-dichloro-2-propyl)phosphate",C016805,"tris(1,3-dichloro-2-propyl)phosphate",https://ctdbase.org/detail.go?type=chem&acc=C016805,147495.0,APCDD1,https://ctdbase.org/detail.go?type=gene&acc=147495,,,147495,APCDD1,9606,Homo sapiens (human),"Tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of APCDD1 mRNA",,,PMID:26179874,https://www.ncbi.nlm.nih.gov/pubmed/26179874,26179874,,
320,1165894,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,91942.0,NDUFAF2,https://ctdbase.org/detail.go?type=gene&acc=91942,,,91942,NDUFAF2,10090,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of NDUFAF2 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
321,1541078,312145,Comparative Toxicogenomics Database (CTD),Wortmannin,D000077191,Wortmannin,https://ctdbase.org/detail.go?type=chem&acc=D000077191,5743.0,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743,PTGS2,9606,Homo sapiens (human),Wortmannin inhibits the reaction [sodium arsenite results in increased expression of PTGS2 protein],,,PMID:23968725,https://www.ncbi.nlm.nih.gov/pubmed/23968725,23968725,,
322,1541079,312145,Comparative Toxicogenomics Database (CTD),Wortmannin,D000077191,Wortmannin,https://ctdbase.org/detail.go?type=chem&acc=D000077191,5743.0,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743,PTGS2,9606,Homo sapiens (human),Wortmannin inhibits the reaction [zinc results in increased expression of PTGS2 protein]|wortmannin inhibits the reaction [zinc results in increased expression of PTGS2 mrna],,,PMID:15980035,https://www.ncbi.nlm.nih.gov/pubmed/15980035,15980035,,
